Barnesiella intestinihominis DSM 21032 is an anaerobe, mesophilic, Gram-negative prokaryote that was isolated from human faeces.
Gram-negative rod-shaped anaerobe mesophilic genome sequence 16S sequence| @ref 20215 |
|
|
| Domain Pseudomonadati |
| Phylum Bacteroidota |
| Class Bacteroidia |
| Order Bacteroidales |
| Family Barnesiellaceae |
| Genus Barnesiella |
| Species Barnesiella intestinihominis |
| Full scientific name Barnesiella intestinihominis Morotomi et al. 2008 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 15518 | CHOPPED MEAT MEDIUM (DSMZ Medium 78) | Medium recipe at MediaDive | Name: CHOPPED MEAT MEDIUM (DSMZ Medium 78) Composition: Ground beef 500.0 g/l Casitone 30.0 g/l Agar 15.0 g/l Ethanol 9.5 g/l (optional) K2HPO4 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl 0.5 g/l Haemin 0.005 g/l (optional) Resazurin 0.001 g/l Vitamin K3 0.0005 g/l (optional) Vitamin K1 (optional) NaOH (optional) Distilled water |
| 31196 | Observationaggregates in chains |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 68380 | 16024 ChEBI | D-mannose | - | fermentation | from API rID32A |
| 31196 | 17234 ChEBI | glucose | + | carbon source | |
| 68380 | 29985 ChEBI | L-glutamate | + | degradation | from API rID32A |
| 31196 | 17716 ChEBI | lactose | + | carbon source | |
| 31196 | 17306 ChEBI | maltose | + | carbon source | |
| 31196 | 37684 ChEBI | mannose | + | carbon source | |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 68380 | 27897 ChEBI | tryptophan | - | energy source | from API rID32A |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | from API rID32A |
| @ref | Chebi-ID | Metabolite | Indole test | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | - | from API rID32A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 31196 | acid phosphatase | + | 3.1.3.2 | |
| 68380 | alanine arylamidase | + | 3.4.11.2 | from API rID32A |
| 31196 | alkaline phosphatase | + | 3.1.3.1 | |
| 68380 | alkaline phosphatase | + | 3.1.3.1 | from API rID32A |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 31196 | alpha-galactosidase | + | 3.2.1.22 | |
| 68380 | alpha-glucosidase | + | 3.2.1.20 | from API rID32A |
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68380 | beta-galactosidase | + | 3.2.1.23 | from API rID32A |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 68380 | glutamate decarboxylase | + | 4.1.1.15 | from API rID32A |
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68380 | L-arginine arylamidase | - | from API rID32A | |
| 68380 | leucine arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | + | 3.4.11.1 | from API rID32A |
| 68380 | N-acetyl-beta-glucosaminidase | + | 3.2.1.52 | from API rID32A |
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68380 | serine arylamidase | - | from API rID32A | |
| 68380 | tryptophan deaminase | - | 4.1.99.1 | from API rID32A |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15518 | - | - | + | + | - | + | +/- | - | - | + | - | - | + | + | - | - | + | - | - | + | +/- | - | - | +/- | + | +/- | - | - | - | |
| 15518 | - | - | +/- | + | - | + | +/- | - | - | + | - | +/- | + | +/- | - | - | + | - | - | + | - | - | - | - | + | - | - | - | - | |
| 15518 | - | - | + | + | - | + | + | - | - | + | - | - | + | +/- | - | - | + | - | - | + | - | - | - | - | + | - | - | - | - |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | - | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
Global distribution of 16S sequence AB547647 (>99% sequence identity) for Barnesiella intestinihominis subclade from Microbeatlas ![]()
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 67770 | Barn_inte_YIT_11860_V1 assembly for Barnesiella intestinihominis YIT 11860 | scaffold | 742726 | 74.37 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | spore_formation | BacteriaNetⓘ | no | 99.70 | no |
| 125439 | motility | BacteriaNetⓘ | no | 65.00 | no |
| 125439 | gram_stain | BacteriaNetⓘ | negative | 99.20 | no |
| 125439 | oxygen_tolerance | BacteriaNetⓘ | anaerobe | 98.80 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | no | 97.27 | no |
| 125438 | anaerobic | anaerobicⓘ | yes | 89.53 | no |
| 125438 | spore-forming | spore-formingⓘ | no | 93.98 | no |
| 125438 | aerobic | aerobicⓘ | no | 94.52 | yes |
| 125438 | thermophilic | thermophileⓘ | no | 95.48 | yes |
| 125438 | flagellated | motile2+ⓘ | no | 87.60 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Barnesiella intestinihominis improves gut microbiota disruption and intestinal barrier integrity in mice with impaired glucose regulation. | Liu X, Wang L, Huang B, Jiao Y, Guan Y, Nuli R. | Front Pharmacol | 10.3389/fphar.2025.1635579 | 2025 | ||
| Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma. | Zhang J, Yang J, Luo J, Wu W, Luo H, Wei W, Lyu H, Wang Y, Yi H, Zhang Y, Fan Z, Lyu H, Kanakaveti VP, Qin B, Yuan P, Yang R, Zhang H, Zuo T, Felsher DW, Lee MH, Li K. | Nat Commun | 10.1038/s41467-025-58407-z | 2025 | ||
| Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility. | Wolter M, Grant ET, Boudaud M, Pudlo NA, Pereira GV, Eaton KA, Martens EC, Desai MS. | Mol Syst Biol | 10.1038/s44320-024-00036-7 | 2024 | ||
| Maternal diet and gut microbiome composition modulate early-life immune development. | Grant ET, Boudaud M, Muller A, Muller A, Macpherson AJ, Desai MS. | EMBO Mol Med | 10.15252/emmm.202217241 | 2023 | ||
| Pathogenicity | Constructing a gnotobiotic mouse model with a synthetic human gut microbiome to study host-microbe cross talk. | Steimle A, De Sciscio A, Neumann M, Grant ET, Pereira GV, Ohno H, Martens EC, Desai MS. | STAR Protoc | 10.1016/j.xpro.2021.100607 | 2021 | |
| Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host. | Pereira GV, Boudaud M, Wolter M, Alexander C, De Sciscio A, Grant ET, Trindade BC, Pudlo NA, Singh S, Campbell A, Shan M, Zhang L, Yang Q, Willieme S, Kim K, Denike-Duval T, Fuentes J, Bleich A, Schmidt TM, Kennedy L, Lyssiotis CA, Chen GY, Eaton KA, Desai MS, Martens EC. | Cell Host Microbe | 10.1016/j.chom.2024.03.001 | 2024 | ||
| Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome. | Steinway SN, Biggs MB, Loughran TP, Papin JA, Albert R. | PLoS Comput Biol | 10.1371/journal.pcbi.1004338 | 2015 | ||
| A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. | Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Nunez G, Martens EC. | Cell | 10.1016/j.cell.2016.10.043 | 2016 | ||
| Phylogeny | Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. | Laursen MF, Laursen RP, Larnkjaer A, Michaelsen KF, Bahl MI, Licht TR. | BMC Microbiol | 10.1186/s12866-017-1090-7 | 2017 | |
| Metabolism | Investigation of the microbial metabolism of carbon dioxide and hydrogen in the kangaroo foregut by stable isotope probing. | Godwin S, Kang A, Gulino LM, Manefield M, Gutierrez-Zamora ML, Kienzle M, Ouwerkerk D, Dawson K, Klieve AV. | ISME J | 10.1038/ismej.2014.25 | 2014 | |
| Bupi Yishen formula against chronic kidney injury via Akkermansia muciniphila mediated group 3 innate lymphoid cells activation to repair intestinal barrier funciton. | Liu W, Zhang Y, Gu S, Zhang, Cai Y, Mo Y, Wu Y, Huang L, Liu X, Lu Z. | Phytomedicine | 10.1016/j.phymed.2025.157412 | 2025 | ||
| Bifidobacterium breve B2798 and Its Heat-Killed Cells Alleviate Inflammation in Rats with DSS Model by Modulating Gut Microbiota. | Feng C, Zhao Y, He Q, Yu J, Sun Z. | Probiotics Antimicrob Proteins | 10.1007/s12602-025-10648-6 | 2025 | ||
| Molecular mechanisms of complex-type N-glycan breakdown and metabolism by the human intestinal bacterium Barnesiella intestinihominis. | Doi K, Mori K, Komatsu M, Shinoda A, Tashiro K, Higuchi Y, Nakayama J, Takegawa K. | J Biosci Bioeng | 10.1016/j.jbiosc.2024.10.006 | 2025 | ||
| Characterization of novel endo-beta-N-acetylglucosaminidases from intestinal Barnesiella intestinihominis that hydrolyze multi-branched complex-type N-glycans. | Doi K, Mitani A, Nakakita SI, Higuchi Y, Takegawa K. | J Biosci Bioeng | 10.1016/j.jbiosc.2023.12.004 | 2024 | ||
| Chelerythrine Protects Against Acetaminophen-Induced Acute Liver Injury: Insights from Gut Microbiota and Multi-Omics Analysis. | Liu J, Zhang Y, Wu H, Yang P, Wang W, Li C, Cao H, Wu J, Sun X. | Antioxidants (Basel) | 10.3390/antiox14091063 | 2025 | ||
| Iron-saturated bovine lactoferrin preserves microbiota diversity and healthy ageing-associated taxa in an in vitro colon model of elderly gut microbiota (Iron-saturated bovine lactoferrin impact on elderly gut microbiota). | Ruiz-Rico M, Ye H, O'Callaghan TF, O'Toole PW, McCarthy EK. | PLoS One | 10.1371/journal.pone.0332631 | 2025 | ||
| Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. | Woodworth MH, Conrad RE, Haldopoulos M, Pouch SM, Babiker A, Mehta AK, Sitchenko KL, Wang CH, Strudwick A, Ingersoll JM, Philippe C, Lohsen S, Kocaman K, Lindner BG, Hatt JK, Jones RM, Miller C, Neish AS, Friedman-Moraco R, Karadkhele G, Liu KH, Jones DP, Mehta CC, Ziegler TR, Weiss DS, Larsen CP, Konstantinidis KT, Kraft CS. | Sci Transl Med | 10.1126/scitranslmed.abo2750 | 2023 | ||
| Dietary Capsaicin Exacerbates Gut Microbiota Dysbiosis and Mental Disorders in Type 1 Diabetes Mice. | Zhang X, Hu H, Zhang Y, Hu S, Lu J, Peng W, Luo D. | Nutrients | 10.3390/nu17030593 | 2025 | ||
| Potential Therapeutic Targets for Androgenetic Alopecia (AGA) in Obese Individuals as Revealed by a Gut Microbiome Analysis: A Mendelian Randomization Study. | Li Y, Liao X, Tang S, Wang Q, Lin H, Yu X, Xiao Y, Tao X, Zhong T. | Nutrients | 10.3390/nu17111892 | 2025 | ||
| Phylogeny | Case report: Tracing in parallel the salivary and gut microbiota profiles to assist Larotrectinib anticancer treatment for NTRK fusion-positive glioblastoma. | Turco L, Della Monica R, Giordano P, Cuomo M, Biazzo M, Mateu B, Di Liello R, Daniele B, Normanno N, De Luca A, Rachiglio AM, Chiaramonte C, Giugliano FM, Chiariotti L, Catapano G, Coretti L, Lembo F. | Front Oncol | 10.3389/fonc.2024.1458990 | 2024 | |
| Gut microbiota mediates the pro-pyroptosis effect of xierezhuyubuxu decoction in hepatocellular carcinoma. | Zeng Z, Feng M, He F, Zhang E, Li X, Cao Z. | Front Microbiol | 10.3389/fmicb.2024.1481111 | 2024 | ||
| Mixed supplementation of dietary inorganic and organic selenium modulated systemic health parameters and fecal microbiota in weaned pigs. | Kyoung H, Shin I, Kim Y, Cho JH, Park KI, Kim Y, Ahn J, Nam J, Kim K, Kang Y, Kim HB, Song M. | Front Vet Sci | 10.3389/fvets.2025.1531336 | 2025 | ||
| Effects of Prebiotics and a Synthetic Microbiome Consortium on the Composition and Metabolites of the Elderly Gut Microbiota In Vitro. | Ye H, Meehan D, Timmons S, O'Toole PW. | J Agric Food Chem | 10.1021/acs.jafc.5c00364 | 2025 | ||
| Gut Commensal Barnesiella Intestinihominis Ameliorates Hyperglycemia and Liver Metabolic Disorders. | Zhang Y, Xu D, Cai X, Xing X, Shao X, Yin A, Zhao Y, Wang M, Fan YN, Liu B, Yang H, Zhou W, Li P. | Adv Sci (Weinh) | 10.1002/advs.202411181 | 2025 | ||
| Phylogeny | BN-BacArena: Bayesian network extension of BacArena for the dynamic simulation of microbial communities. | Blasco T, Balzerani F, Valcarcel LV, Larranaga P, Bielza C, Francino MP, Rufian-Henares JA, Planes FJ, Perez-Burillo S. | Bioinformatics | 10.1093/bioinformatics/btae266 | 2024 | |
| Gut microbiota and breast cancer risk: a Mendelian randomization study stratified by ER status | Yue J, Gu L, Chen S, Wen F, Huang G. | Discov Oncol | 2025 | |||
| TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients. | Tsakmaklis A, Farowski F, Zenner R, Lesker TR, Strowig T, Schlosser H, Lehmann J, von Bergwelt-Baildon M, Mauch C, Schlaak M, Knuever J, Schweinsberg V, Heinzerling LM, Vehreschild MJGT. | BMC Cancer | 10.1186/s12885-023-11551-5 | 2023 | ||
| Gut microbiome alterations in IgG4-related ophthalmic disease. | Ren T, Li J, Liu R, Wang N, Guo Q, Xu L, Yan H, Zhang Y, Ma J. | BMC Microbiol | 10.1186/s12866-025-04350-4 | 2025 | ||
| A ferroptosis-related risk model for non-coding RNA AC002331.1 in colon cancer: construction via competing endogenous RNA network analysis. | Liu J, Zhang C, Ma B, Qi J, Zhang X, Zhao H. | Discov Oncol | 10.1007/s12672-025-03351-z | 2025 | ||
| Lactobacillus casei Zhang exerts anti-obesity effect to obese glut1 and gut-specific-glut1 knockout mice via gut microbiota modulation mediated different metagenomic pathways. | He Q, Zhang Y, Ma D, Zhang W, Zhang H. | Eur J Nutr | 10.1007/s00394-021-02764-0 | 2022 | ||
| A Literature Review on the Impact of the Gut Microbiome on Cancer Treatment Efficacy, Disease Evolution and Toxicity: The Implications for Hematological Malignancies. | Dumitru IG, Todor SB, Ichim C, Helgiu C, Helgiu A. | J Clin Med | 10.3390/jcm14092982 | 2025 | ||
| Cerebral small vessel disease burden is associated with decreased abundance of gut Barnesiella intestinihominis bacterium in the Framingham Heart Study. | Fongang B, Satizabal C, Kautz TF, Wadop YN, Muhammad JAS, Vasquez E, Mathews J, Gireud-Goss M, Saklad AR, Himali J, Beiser A, Cavazos JE, Mahaney MC, Maestre G, DeCarli C, Shipp EL, Vasan RS, Seshadri S. | Sci Rep | 10.1038/s41598-023-40872-5 | 2023 | ||
| Pathogenicity | The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions. | Qasem HH, El-Sayed WM. | Clin Exp Med | 10.1007/s10238-024-01523-9 | 2024 | |
| Interplay of Gut Microbiota, Biologic Agents, and Postoperative Anastomotic Leakage in Inflammatory Bowel Disease: A Narrative Review | Menni A, Kyriazopoulou E, Karakike E, Tzikos G, Filidou E, Kotzampassi K. | Int J Mol Sci | 2025 | |||
| Genetics | Comparison Of The Gut Microbiota In Different Age Groups In China. | Yan H, Qin Q, Yan S, Chen J, Yang Y, Li T, Gao X, Ding S. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.877914 | 2022 | |
| Pathogenicity | Matrine protects against DSS-induced murine colitis by improving gut barrier integrity, inhibiting the PPAR-alpha signaling pathway, and modulating gut microbiota. | Yao H, Shi Y, Yuan J, Sa R, Chen W, Wan X. | Int Immunopharmacol | 10.1016/j.intimp.2021.108091 | 2021 | |
| Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet. | Marcos-Zambrano LJ, Lacruz-Pleguezuelos B, Aguilar-Aguilar E, Marcos-Pasero H, Valdes A, Loria-Kohen V, Cifuentes A, Ramirez de Molina A, Diaz-Ruiz A, Pancaldi V, Carrillo de Santa Pau E. | mSystems | 10.1128/msystems.00143-25 | 2025 | ||
| Phylogeny | The gut microbiota in experimental abdominal aortic aneurysm. | Xiao J, Wei Z, Yang C, Dai S, Wang X, Shang Y. | Front Cardiovasc Med | 10.3389/fcvm.2023.1051648 | 2023 | |
| Pathogenicity | High carbohydrate diet decreases microbial diversity and increases IL-1beta levels in mice colon. | Ulutas MS, Aydin E, Cebeci A. | Food Sci Biotechnol | 10.1007/s10068-024-01581-5 | 2024 | |
| Genetics | Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study. | Al Radi ZMA, Prins FM, Collij V, Vich Vila A, Festen EAM, Dijkstra G, Weersma RK, Klaassen MAY, Gacesa R. | Inflamm Bowel Dis | 10.1093/ibd/izae064 | 2024 | |
| Effect of the gut microbiome, skin microbiome, plasma metabolome, white blood cells subtype, immune cells, inflammatory proteins, and inflammatory cytokines on asthma: a two-sample Mendelian randomized study and mediation analysis. | Guo W, Hong E, Ma H, Wang J, Wang Q. | Front Immunol | 10.3389/fimmu.2025.1436888 | 2025 | ||
| Pathogenicity | Associations Between the Gut Microbiome, Inflammation, and Cardiovascular Profiles in People With Human Immunodeficiency Virus. | MacCann R, Li J, Leon AAG, Negi R, Alalwan D, Tinago W, McGettrick P, Cotter AG, Landay A, Sabin C, O'Toole PW, Mallon PWG, Understanding the Pathology of Comorbid Disease in HIV-Infected Individuals (HIV UPBEAT) Study Group . | J Infect Dis | 10.1093/infdis/jiaf043 | 2025 | |
| Species-level enterosignatures predict clinical phenotypes in chronic hepatitis B and causal triangulation of gut-metabolite-CHB interactions. | Yuan T, Chen J, Yang J, Li L, Lu S, Pu J, Sun Y, Lin W, Lu Y, Zhu Z, Zheng H, Xu J. | Front Microbiol | 10.3389/fmicb.2025.1683451 | 2025 | ||
| Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review. | Lim MY, Hong S, Nam YD. | Front Immunol | 10.3389/fimmu.2024.1512683 | 2024 | ||
| Systematic review of bidirectional interaction between gut microbiome, miRNAs, and human pathologies. | Drago L, De La Motte LR, Deflorio L, Sansico DF, Salvatici M, Micaglio E, Biazzo M, Giarritiello F. | Front Microbiol | 10.3389/fmicb.2025.1540943 | 2025 | ||
| Concomitant decrease of double-positive lymphocyte population CD4CD8alphaalpha and Faecalibacterium prausnitzii in patients with colorectal cancer. | Touchefeu Y, Duchalais E, Bruley des Varannes S, Alameddine J, Mirallie E, Matysiak-Budnik T, Le Bastard Q, Javaudin F, Rimbert M, Jotereau F, Montassier E. | Eur J Gastroenterol Hepatol | 10.1097/meg.0000000000001842 | 2021 | ||
| Gut Microbiome rewiring via fecal transplants: Uncovering therapeutic avenues in Alzheimer's disease models. | Upadhyay P, Kumar S, Tyagi A, Tyagi AR, Barbhuyan T, Gupta S. | BMC Neurosci | 10.1186/s12868-025-00953-9 | 2025 | ||
| Pathogenicity | Engraftment of aging-related human gut microbiota and the effect of a seven-species consortium in a pre-clinical model. | Ye H, Ghosh TS, Hueston CM, Vlckova K, Golubeva AV, Hyland NP, O'Toole PW. | Gut Microbes | 10.1080/19490976.2023.2282796 | 2023 | |
| Genetics | Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer's disease pathology. | Fan KC, Lin CC, Chiu YL, Koh SH, Liu YC, Chuang YF. | Alzheimers Res Ther | 10.1186/s13195-025-01769-9 | 2025 | |
| Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder. | Bui TA, O'Croinin BR, Dennett L, Winship IR, Greenshaw AJ. | Microbiology (Reading) | 10.1099/mic.0.001568 | 2025 | ||
| Rapeseed Meal as an Alternative Protein Source in Fish Feed and Its Impact on Growth Parameters, Digestive Tract, and Gut Microbiota. | Karolina WA, Justyna N. | Animals (Basel) | 10.3390/ani15091264 | 2025 | ||
| Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy. | Golcic M, Simetic L, Herceg D, Blazicevic K, Kendel Jovanovic G, Drazic I, Belancic A, Skocibusic N, Palcevski D, Rubinic I, Vlahovic-Palcevski V, Majnaric T, Dobrila-Dintinjana R, Plestina S. | Cancers (Basel) | 10.3390/cancers15113052 | 2023 | ||
| What Is the Role of the Gut Microbiota in Anastomotic Leakage After Colorectal Resection? A Scoping Review of Clinical and Experimental Studies. | Lianos GD, Frountzas M, Kyrochristou ID, Sakarellos P, Tatsis V, Kyrochristou GD, Bali CD, Gazouli M, Mitsis M, Schizas D. | J Clin Med | 10.3390/jcm13226634 | 2024 | ||
| Self-Initiated Dietary Adjustments Alter Microbiota Abundances: Implications for Perceived Health. | Willems A, Sura-de Jong M, Klaassens E, van den Bogert B, van Beek A, van Dijk G. | Nutrients | 10.3390/nu16203544 | 2024 | ||
| Impact of occupational pesticide exposure on the human gut microbiome. | Gois MFB, Fernandez-Pato A, Huss A, Gacesa R, Wijmenga C, Weersma RK, Fu J, Vermeulen RCH, Zhernakova A, Lenters VC, Kurilshikov A. | Front Microbiol | 10.3389/fmicb.2023.1223120 | 2023 | ||
| Pathogenicity | Immunomodulatory Effects of a Probiotic Mixture: Alleviating Colitis in a Mouse Model through Modulation of Cell Activation Markers and the Gut Microbiota. | Ryu HM, Islam SMS, Riaz B, Sayeed HM, Choi B, Sohn S. | Int J Mol Sci | 10.3390/ijms25168571 | 2024 | |
| Community metabolic modeling of host-microbiota interactions through multi-objective optimization. | Lambert A, Budinich M, Mahe M, Chaffron S, Eveillard D. | iScience | 10.1016/j.isci.2024.110092 | 2024 | ||
| Role of preoperative gut microbiota on colorectal anastomotic leakage: preliminary results. | Palmisano S, Campisciano G, Iacuzzo C, Bonadio L, Zucca A, Cosola D, Comar M, de Manzini N. | Updates Surg | 10.1007/s13304-020-00720-x | 2020 | ||
| Genetics | Microbiome, resistome, and potential transfer of antibiotic resistance genes in Chinese wet market under One Health sectors. | Yang J, Wang L, Liang Q, Wang Y, Yang X, Wu X, Pei X. | BMC Microbiol | 10.1186/s12866-025-04115-z | 2025 | |
| Phylogeny | Compositional alterations of the gut microbiota in acute myocardial infarction patients with type 2 diabetes mellitus. | Lei C, Zhang X, Chen E, Lin L, Zhou Z, Wang Z, Liu T, Liu Z. | Ann Transl Med | 10.21037/atm-22-3521 | 2023 | |
| Pathogenicity | Potential roles of the interactions between gut microbiota and metabolites in LPS-induced intrauterine inflammation (IUI) and associated preterm birth (PTB). | Jia B, Tang L, Liu H, Chen W, Chen Q, Zhong M, Yin A. | J Transl Med | 10.1186/s12967-023-04603-8 | 2024 | |
| Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors. | Lin A, Huang L, Jiang A, Zhu L, Mou W, Li Y, Zhang C, Liu Z, Zhang J, Cheng Q, Wei T, Luo P. | BMC Med | 10.1186/s12916-025-04183-y | 2025 | ||
| Phylogeny | Cellulase activity and age-based variation of intestinal microbiota in Hezuo pigs. | Liang Y, Wang F, Jia R, Li J, Wang L, Li Y, Li Y, Gun S, Yang Q. | Front Microbiol | 10.3389/fmicb.2025.1599847 | 2025 | |
| Genetics | Metabolic response of intestinal microbiota to guar gum consumption. | Barber C, Sabater C, Guarner F, Margolles A, Azpiroz F. | Front Nutr | 10.3389/fnut.2023.1160694 | 2023 | |
| Beneficial Effects of In Vitro Reconstructed Human Gut Microbiota by Ginseng Extract Fermentation on Intestinal Cell Lines. | Finazzi M, Bovio F, Forcella M, Lasagni M, Fusi P, Di Gennaro P. | Microorganisms | 10.3390/microorganisms13010192 | 2025 | ||
| Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma. | Dizman N, Hsu J, Bergerot PG, Gillece JD, Folkerts M, Reining L, Trent J, Highlander SK, Pal SK. | Cancer Med | 10.1002/cam4.3569 | 2021 | ||
| Modulating Gut Microbiota with Dietary Components: A Novel Strategy for Cancer-Depression Comorbidity Management. | Dai H, Yang H, Wang R, Wang X, Zhang X. | Nutrients | 10.3390/nu17091505 | 2025 | ||
| Metabolism | Effect of Lactobacillus plantarum Extracellular Vesicles on Lipid Metabolism in Mice Fed a High-Fat Diet. | Xu SS, Yu CJ, Qin MY, Zhang Y, Jiang JP, Liu W, Pan Y, Zhang S, Zhao XY. | Mol Nutr Food Res | 10.1002/mnfr.70183 | 2025 | |
| Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism. | Bai X, Duan Z, Deng J, Zhang Z, Fu R, Zhu C, Fan D. | J Adv Res | 10.1016/j.jare.2024.06.028 | 2025 | ||
| Ginsenoside Rk3 modulates gut microbiota and regulates immune response of group 3 innate lymphoid cells to against colorectal tumorigenesis. | Bai X, Fu R, Liu Y, Deng J, Fei Q, Duan Z, Zhu C, Fan D. | J Pharm Anal | 10.1016/j.jpha.2023.09.010 | 2024 | ||
| Consumption of only wild foods induces large scale, partially persistent alterations to the gut microbiome. | Rampelli S, Pomstra D, Barone M, Fabbrini M, Turroni S, Candela M, Henry AG. | Sci Rep | 10.1038/s41598-025-00319-5 | 2025 | ||
| Age and aging process alter the gut microbes. | Zhanbo Q, Jing Z, Shugao H, Yinhang W, Jian C, Xiang Y, Feimin Z, Jian L, Xinyue W, Wei W, Shuwen H. | Aging (Albany NY) | 10.18632/aging.205728 | 2024 | ||
| Phylogeny | The intensive physical activity causes changes in the composition of gut and oral microbiota. | Urban S, Chmura O, Wator J, Panek P, Zapala B. | Sci Rep | 10.1038/s41598-024-71684-w | 2024 | |
| The science behind TCM and Gut microbiota interaction-their combinatorial approach holds promising therapeutic applications. | Xia W, Liu B, Tang S, Yasir M, Khan I. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.875513 | 2022 | ||
| Pathogenicity | The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities. | George MY, Gamal NK, Mansour DE, Famurewa AC, Bose D, Messiha PA, Cerchione C. | Hematol Rep | 10.3390/hematolrep17060056 | 2025 | |
| Potential application of pig (Sus scrofa domestica) skin peptide-iron chelates in the treatment of iron deficiency anemia and regulation of intestinal flora metabolism. | Huang S, Deng H, Liang K, Zhao X, Zhang J. | Front Nutr | 10.3389/fnut.2025.1553668 | 2025 | ||
| Gut microbiome is associated with radiotherapy response in lung cancer patients with brain metastases. | Liang F, Sun Y, Yang J, Shen Z, Wang G, Zhu J, Zhou C, Xia Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1562831 | 2025 | ||
| Bifidobacterium as a Potential Biomarker of Sarcopenia in Elderly Women. | Wang Z, Xu X, Deji Y, Gao S, Wu C, Song Q, Shi Z, Xiang X, Zang J, Su J. | Nutrients | 10.3390/nu15051266 | 2023 | ||
| Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients. | Grenda A, Iwan E, Krawczyk P, Frak M, Chmielewska I, Bomba A, Giza A, Rolska-Kopinska A, Szczyrek M, Kieszko R, Kucharczyk T, Jarosz B, Wasyl D, Milanowski J. | Cancers (Basel) | 10.3390/cancers14246250 | 2022 | ||
| Uncovering the complexity of childhood undernutrition through strain-level analysis of the gut microbiome. | Chang B, Zhang W, Wang Y, Zhang Y, Zhong S, Gao P, Wang L, Zhao Z. | BMC Microbiol | 10.1186/s12866-024-03211-w | 2024 | ||
| Synergistic Effects of Probiotics and Lifestyle Interventions on Intestinal Microbiota Composition and Clinical Outcomes in Obese Adults. | Florencio GP, Xavier AR, Natal ACC, Sadoyama LP, Pena GDG, Menezes RP, Sadoyama Leal G, Patrizzi LJ, Roder DVDB. | Metabolites | 10.3390/metabo15020070 | 2025 | ||
| B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients. | Vietsch EE, Latifi D, Verheij M, van der Oost EWA, de Wilde RF, Haen R, van den Boom AL, Koerkamp BG, Doornebosch PG, van Verschuer VMT, Ooms AHAG, Mohammad F, Willemsen M, Aerts JGJV, Krog RT, de Miranda NFCC, van den Bosch TPP, Mueller YM, Katsikis PD, van Eijck CHJ. | Front Immunol | 10.3389/fimmu.2023.1230306 | 2023 | ||
| Probiotics supplementation or probiotic-fortified products on sarcopenic indices in older adults: systematic review and meta-analysis from recent randomized controlled trials. | Handajani YS, Turana Y, Hengky A, Hamid G, Schroeder-Butterfill E, Kristian K. | Front Aging | 10.3389/fragi.2024.1307762 | 2024 | ||
| Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications | Yan K, Sun X, Wang X, Zheng J, Yu H. | Nutrients | 2025 | |||
| Matrine Protects Intestinal Barrier Function via MicroRNA-155 Through ROCK1-Signaling Pathway. | Yu D, Su D, Liu Z. | Turk J Gastroenterol | 10.5152/tjg.2023.21884 | 2023 | ||
| Current Insights: The Impact of Gut Microbiota on Postoperative Complications in Visceral Surgery-A Narrative Review. | Lederer AK, Chikhladze S, Kohnert E, Huber R, Muller A. | Diagnostics (Basel) | 10.3390/diagnostics11112099 | 2021 | ||
| Phylogeny | Chinese herbal medicine, Tongxieyaofang, alleviates diarrhea via gut microbiota remodeling: evidence from network pharmacology and full-length 16S rRNA gene sequencing. | Shao H, Wang L, Zhang H. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1502373 | 2024 | |
| The Interplay Between the Gut Microbiota and Colorectal Cancer: A Review of the Literature. | Cintoni M, Palombaro M, Zoli E, D'Agostino G, Pulcini G, Leonardi E, Raoul P, Rinninella E, De Maio F, Capristo E, Gasbarrini A, Mele MC. | Microorganisms | 10.3390/microorganisms13061410 | 2025 | ||
| Genetics | The genetic diversity and populational specificity of the human gut virome at single-nucleotide resolution. | Wang X, Dong Q, Huang P, Yang S, Gao M, Zhang C, Zhang C, Deng Y, Huang Z, Ma B, Jiao Y, Zhou Y, Wu T, Zou H, Shi J, Sheng Y, Wang Y, Consortium C, Tang L, Hu S, Duan Y, Sun W, Chen W, Zhai Q, Kong X, Chen L. | Microbiome | 10.1186/s40168-025-02185-9 | 2025 | |
| Effects of exercise and physical activity on gut microbiota composition and function in older adults: a systematic review. | Aya V, Jimenez P, Munoz E, Ramirez JD. | BMC Geriatr | 10.1186/s12877-023-04066-y | 2023 | ||
| Guardians in the Gut: Mechanistic Insights into a Hidden Ally Against Triple-Negative Breast Cancer. | Jaye K, Alsherbiny MA, Chang D, Li CG, Bhuyan DJ. | Cancers (Basel) | 10.3390/cancers17193248 | 2025 | ||
| Collagenase-producing bacteria are common in anastomotic leakage after colorectal surgery: a systematic review. | Jorgensen AB, Jonsson I, Friis-Hansen L, Brandstrup B. | Int J Colorectal Dis | 10.1007/s00384-023-04562-y | 2023 | ||
| The P4 Study: Postpartum Maternal and Infant Faecal Microbiome 6 Months After Hypertensive Versus Normotensive Pregnancy. | Susic DF, Wang L, Roberts LM, Bai M, Gia A, McGovern E, Jiang XT, Davis GK, El-Omar E, Henry A. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.646165 | 2022 | ||
| Modulation of the Gut Microbiota by the Plantaricin-Producing Lactiplantibacillus plantarum D13, Analysed in the DSS-Induced Colitis Mouse Model. | Butorac K, Novak J, Banic M, Lebos Pavunc A, Culjak N, Orsolic N, Odeh D, Perica J, Suskovic J, Kos B. | Int J Mol Sci | 10.3390/ijms242015322 | 2023 | ||
| Phylogeny | Changes in the Gut and Oral Microbiome in Children with Phenylketonuria in the Context of Dietary Restrictions-A Preliminary Study. | Ostrowska M, Nowosad K, Mikoluc B, Szczerba H, Komon-Janczara E. | Nutrients | 10.3390/nu16223915 | 2024 | |
| Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review. | Szklenarik G, Kiraly P, Szegvari G, Dora D, Lohinai Z. | Front Med (Lausanne) | 10.3389/fmed.2024.1488377 | 2024 | ||
| Pathogenicity | Modulation of the Gut-Lung Axis by Water Kefir and Kefiran and Their Impact on Toll-like Receptor 3-Mediated Respiratory Immunity. | Dentice Maidana S, Arganaraz Aybar JN, Albarracin L, Imamura Y, Arellano-Arriagada L, Namai F, Suda Y, Nishiyama K, Villena J, Kitazawa H. | Biomolecules | 10.3390/biom14111457 | 2024 | |
| Exploring the role of gut microbiota in advancing personalized medicine. | Huang G, Khan R, Zheng Y, Lee PC, Li Q, Khan I. | Front Microbiol | 10.3389/fmicb.2023.1274925 | 2023 | ||
| Metabolism | Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer. | Zou S, Yang C, Zhang J, Zhong D, Meng M, Zhang L, Chen H, Fang L. | J Transl Med | 10.1186/s12967-024-04984-4 | 2024 | |
| Microbiota and Hematological Diseases. | D'Angelo G. | Int J Hematol Oncol Stem Cell Res | 10.18502/ijhoscr.v16i3.10139 | 2022 | ||
| Characterization and Evaluation of Lactobacillus plantarum LC5.2 Isolated from Thai Native Pigs for its Probiotic Potential in Gut Microbiota Modulation and Immune Enhancement. | Khongkool K, Taweechotipatr M, Payungporn S, Sawaswong V, Lertworapreecha M. | J Microbiol Biotechnol | 10.4014/jmb.2503.03028 | 2025 | ||
| Enzymology | Gut microbiota modulation and immunity enhancement by Bacillus amyloliquefaciens NL1.2: A fiber-degrading probiotic isolated from native Thai swine. | Khongkool K, Taweechotipatr M, Payungporn S, Sawaswong V, Lertworapreecha M. | Vet World | 10.14202/vetworld.2025.1487-1507 | 2025 | |
| Metabolism | Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review. | David A, Lev-Ari S. | Integr Cancer Ther | 10.1177/15347354241269870 | 2024 | |
| Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. | Daillere R, Vetizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Eggermont A, Tartour E, Johannes L, Woerther PL, Chachaty E, Soria JC, Golden E, Formenti S, Plebanski M, Madondo M, Rosenstiel P, Raoult D, Cattoir V, Boneca IG, Chamaillard M, Zitvogel L. | Immunity | 10.1016/j.immuni.2016.09.009 | 2016 | ||
| Impact of broad-spectrum antibiotics on the gut-microbiota-spleen-brain axis. | Wan X, Eguchi A, Sakamoto A, Fujita Y, Yang Y, Qu Y, Hatano M, Mori C, Hashimoto K. | Brain Behav Immun Health | 10.1016/j.bbih.2022.100573 | 2023 | ||
| Microbial Features Linked to Medication Strategies in Cardiometabolic Disease Management. | Shearer J, Shah S, Shen-Tu G, Schlicht K, Laudes M, Mu C. | ACS Pharmacol Transl Sci | 10.1021/acsptsci.3c00261 | 2024 | ||
| Muscle strength is increased in mice that are colonized with microbiota from high-functioning older adults. | Fielding RA, Reeves AR, Jasuja R, Liu C, Barrett BB, Lustgarten MS. | Exp Gerontol | 10.1016/j.exger.2019.110722 | 2019 | ||
| The Hazards of Probiotics on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice Undergoing Chemotherapy. | Huang FC, Huang SC. | Biomedicines | 10.3390/biomedicines12020253 | 2024 | ||
| Integrative multiomics analysis reveals association of gut microbiota and its metabolites with susceptibility to keloids. | Li D, Li M, Gao H, Hu K, Xie R, Fan J, Huang M, Liao C, Han C, Guo Z, Chen X, Li M. | Front Microbiol | 10.3389/fmicb.2024.1475984 | 2024 | ||
| Genetics | A Comparative Analysis of Biosynthetic Gene Clusters in Lean and Obese Humans. | Wang S, Li N, Li N, Zou H, Wu M. | Biomed Res Int | 10.1155/2019/6361320 | 2019 | |
| Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage. | Lu X, Ma J, Li R. | Sci Rep | 10.1038/s41598-023-39444-4 | 2023 | ||
| Pathogenicity | Blueberry Supplementation and Skin Health. | Ivarsson J, Pecorelli A, Lila MA, Valacchi G. | Antioxidants (Basel) | 10.3390/antiox12061261 | 2023 | |
| The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors. | Wu Z, Zhang S, Li L, Huang Z, Huang D, Hu Y. | Front Oncol | 10.3389/fonc.2022.887383 | 2022 | ||
| Pathogenicity | Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice. | Smith BJ, Miller RA, Schmidt TM. | mSphere | 10.1128/msphere.00851-21 | 2021 | |
| Gastrointestinal complaints after Roux-en-Y gastric bypass surgery. Impact of microbiota and its metabolites. | Custers E, van der Burgh YGR, Vreeken D, Schuren F, van den Broek TJ, Verschuren L, de Blaauw I, Bouwens M, Kleemann R, Kiliaan AJ, Hazebroek EJ. | Heliyon | 10.1016/j.heliyon.2024.e39899 | 2024 | ||
| Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE. | Bianchimano P, Iwanowski K, Smith EM, Cantor A, Leone P, Bongers G, Gonzalez CG, Hongsup Y, Elias J, Weiner HL, Clemente JC, Tankou SK. | iScience | 10.1016/j.isci.2023.108143 | 2023 | ||
| Genetics | Gut resistome of NSCLC patients treated with immunotherapy. | Iwan E, Grenda A, Bomba A, Bielinska K, Wasyl D, Kieszko R, Rolska-Kopinska A, Chmielewska I, Krawczyk P, Rybczynska-Tkaczyk K, Olejnik M, Milanowski J. | Front Genet | 10.3389/fgene.2024.1378900 | 2024 | |
| Effect of Mannan-rich fraction supplementation on commercial broiler intestinum tenue and cecum microbiota. | Leigh RJ, Corrigan A, Murphy RA, Walsh F. | Anim Microbiome | 10.1186/s42523-022-00208-6 | 2022 | ||
| Population-level gut microbiome and its associations with environmental factors and metabolic disorders in Southwest China. | Qu Q, Dou Q, Xiang Z, Yu B, Chen L, Fan Z, Zhao X, Yang S, Zeng P. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00661-6 | 2025 | ||
| Impact of Combined Prebiotic Galacto-Oligosaccharides and Bifidobacterium breve-Derived Postbiotic on Gut Microbiota and HbA1c in Prediabetic Adults: A Double-Blind, Randomized, Placebo-Controlled Study. | Beteri B, Barone M, Turroni S, Brigidi P, Tzortzis G, Vulevic J, Sekulic K, Motei DE, Costabile A. | Nutrients | 10.3390/nu16142205 | 2024 | ||
| Genetics | Metagenome-based characterization of the gut bacteriome, mycobiome, and virome in patients with chronic hepatitis B-related liver fibrosis. | Chen W, Liang F, Zhang Y, Zhang Y, Lv J, Jin X, Ran Y, Li S, Sun W. | Front Microbiol | 10.3389/fmicb.2024.1449090 | 2024 | |
| Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease. | Choi JY, Shim B, Park Y, Kang YA. | Korean J Intern Med | 10.3904/kjim.2023.097 | 2023 | ||
| Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021). | Yang S, Zhao S, Ye Y, Jia L, Lou Y. | Front Immunol | 10.3389/fimmu.2022.952546 | 2022 | ||
| Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligo. | Luan M, Niu M, Yang P, Han D, Zhang Y, Li W, He Q, Zhao Y, Mao B, Chen J, Mou K, Li P. | BMC Microbiol | 10.1186/s12866-023-03020-7 | 2023 | ||
| Phylogeny | Characteristics of gut microbiota in people with obesity. | Duan M, Wang Y, Zhang Q, Zou R, Guo M, Zheng H. | PLoS One | 10.1371/journal.pone.0255446 | 2021 | |
| Assessing the gut microbiota composition in older adults: connections to physical activity and healthy ageing. | Ramos C, Magistro D, Walton GE, Whitham A, Camp N, Poveda C, Gibson GR, Hough J, Kinnear W, Hunter K. | Geroscience | 10.1007/s11357-025-01605-w | 2025 | ||
| Eco-evolutionary feedbacks in the human gut microbiome. | Good BH, Rosenfeld LB. | Nat Commun | 10.1038/s41467-023-42769-3 | 2023 | ||
| Impact of urbanization on gut microbiome mosaics across geographic and dietary contexts. | Vinogradova E, Mukhanbetzhanov N, Nurgaziyev M, Jarmukhanov Z, Aipova R, Sailybayeva A, Bekbossynova M, Kozhakhmetov S, Kushugulova A. | mSystems | 10.1128/msystems.00585-24 | 2024 | ||
| Monascus red pigments alleviate high-fat and high-sugar diet-induced NAFLD in mice by modulating the gut microbiota and metabolites. | Gao W, Chen X, Wu S, Jin L, Chen X, Mao G, Wan X, Xing W. | Food Sci Nutr | 10.1002/fsn3.4208 | 2024 | ||
| Identification of Muscle Strength-Related Gut Microbes through Human Fecal Microbiome Transplantation. | Ahn JS, Koo BC, Choi YJ, Jung WW, Kim HS, Lee SJ, Hong ST, Chung HJ. | Int J Mol Sci | 10.3390/ijms25010662 | 2024 | ||
| Akkermansia muciniphila alleviates abdominal aortic aneurysms via restoring CITED2 activated by EPAS1. | Wang S, Shi H, Cheng Y, Jiang L, Lou Y, Kumar M, Sun M, Shao X, Zhao X, Wang B. | Infect Immun | 10.1128/iai.00172-24 | 2024 | ||
| Pathogenicity | The Influence of Probiotic Supplementation on the Obesity Indexes, Neuroinflammatory and Oxidative Stress Markers, Gut Microbial Diversity, and Working Memory in Obese Thai Children. | Khongtan S, Sivamaruthi BS, Thangaleela S, Kesika P, Bharathi M, Sirilun S, Choeisoongnern T, Peerajan S, Sittiprapaporn P, Chaiyasut C. | Foods | 10.3390/foods12213890 | 2023 | |
| Beneficial effects of Lactobacillus plantarum on growth performance, immune status, antioxidant function and intestinal microbiota in broilers. | Xiao X, Cui T, Qin S, Wang T, Liu J, Sa L, Wu Y, Zhong Y, Yang C. | Poult Sci | 10.1016/j.psj.2024.104280 | 2024 | ||
| Effects of Designed Herbal Formula on Growth Performance, Blood Indices, Organ Traits, and Cecum Microbiology in Broilers. | Sun Y, Zhang M, Shi D, Dai X, Li X. | Vet Sci | 10.3390/vetsci11030107 | 2024 | ||
| Evidence from Animal Models: Is a Restricted or Conventional Intestinal Microbiota Composition Predisposing to Risk for High-LET Radiation Injury? | Maier I, Schiestl RH. | Radiat Res | 10.1667/rr13837.1 | 2015 | ||
| Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma. | Limeta A, Ji B, Levin M, Gatto F, Nielsen J. | JCI Insight | 10.1172/jci.insight.140940 | 2020 | ||
| Characterization of Novel Exopolysaccharides from Enterococcus hirae WEHI01 and Its Immunomodulatory Activity. | Jia K, Wei M, He Y, Wang Y, Wei H, Tao X. | Foods | 10.3390/foods11213538 | 2022 | ||
| The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy. | Kim J, Lee HK. | Mol Cells | 10.14348/molcells.2021.0032 | 2021 | ||
| Pathogenicity | Phenotyping of Fecal Microbiota of Winnie, a Rodent Model of Spontaneous Chronic Colitis, Reveals Specific Metabolic, Genotoxic, and Pro-inflammatory Properties. | Tala A, Guerra F, Resta SC, Calcagnile M, Barca A, Tredici SM, De Donno MD, Vacca M, Liso M, Chieppa M, De Angelis M, Verri T, Bozzetti MG, Bucci C, Alifano P. | Inflammation | 10.1007/s10753-022-01706-0 | 2022 | |
| Vitamin C improves gut Bifidobacteria in humans. | Hazan S, Dave S, Papoutsis AJ, Deshpande N, Howell MC, Martin LM. | Future Microbiol | 10.2217/fmb-2022-0209 | 2025 | ||
| Increasing buffering capacity enhances rumen fermentation characteristics and alters rumen microbiota composition of high-concentrate fed Hanwoo steers. | Ramos SC, Kim SH, Jeong CD, Mamuad LL, Son AR, Kang SH, Cho YI, Kim TG, Lee JS, Cho KK, Lee SS, Lee SS. | Sci Rep | 10.1038/s41598-022-24777-3 | 2022 | ||
| Holstein and Jersey Steers Differ in Rumen Microbiota and Enteric Methane Emissions Even Fed the Same Total Mixed Ration. | Islam M, Kim SH, Ramos SC, Mamuad LL, Son AR, Yu Z, Lee SS, Cho YI, Lee SS. | Front Microbiol | 10.3389/fmicb.2021.601061 | 2021 | ||
| The Role of Tumor and Host Microbiome on Immunotherapy Response in Urologic Cancers. | Pfail J, Drobner J, Doppalapudi K, Saraiya B, Packiam V, Ghodoussipour S. | J Cancer Immunol (Wilmington) | 10.33696/cancerimmunol.6.078 | 2024 | ||
| Gut microbiota in acute leukemia: Current evidence and future directions. | Zhou Y, Zhou C, Zhang A. | Front Microbiol | 10.3389/fmicb.2022.1045497 | 2022 | ||
| Genetics | Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis. | Zeybel M, Arif M, Li X, Altay O, Yang H, Shi M, Akyildiz M, Saglam B, Gonenli MG, Yigit B, Ulukan B, Ural D, Shoaie S, Turkez H, Nielsen J, Zhang C, Uhlen M, Boren J, Mardinoglu A. | Adv Sci (Weinh) | 10.1002/advs.202104373 | 2022 | |
| Potential interaction between timing of infant complementary feeding and breastfeeding duration in determination of early childhood gut microbiota composition and BMI. | Differding MK, Doyon M, Bouchard L, Perron P, Guerin R, Asselin C, Masse E, Hivert MF, Mueller NT. | Pediatr Obes | 10.1111/ijpo.12642 | 2020 | ||
| Genetics | Exploring the Microbial Community and Functional Characteristics of the Livestock Feces Using the Whole Metagenome Shotgun Sequencing. | Kim H, Kim ES, Cho JH, Song M, Cho JH, Kim S, Keum GB, Kwak J, Doo H, Pandey S, Park SH, Lee JH, Jung H, Hur TY, Kim JK, Oh KK, Kim HB, Lee JH. | J Microbiol Biotechnol | 10.4014/jmb.2209.09013 | 2023 | |
| Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies. | Rinninella E, Raoul P, Cintoni M, Palombaro M, Pulcini G, Gasbarrini A, Gasbarrini A, Mele MC. | Microorganisms | 10.3390/microorganisms9071469 | 2021 | ||
| Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes? | Hossain SM, Ly K, Sung YJ, Braithwaite A, Li K. | Int J Mol Sci | 10.3390/ijms251810120 | 2024 | ||
| Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition. | Govaert M, Rotsaert C, Vannieuwenhuyse C, Duysburgh C, Medlin S, Marzorati M, Jarrett H. | Nutrients | 10.3390/nu16162791 | 2024 | ||
| Intestinal microbiota reduces genotoxic endpoints induced by high-energy protons. | Maier I, Berry DM, Schiestl RH. | Radiat Res | 10.1667/rr13352.1 | 2014 | ||
| Causal relationship between the gut microbiome and basal cell carcinoma, melanoma skin cancer, ease of skin tanning: evidence from three two-sample mendelian randomisation studies. | Lou J, Cui S, Li J, Jin G, Fan Y, Huang N. | Front Immunol | 10.3389/fimmu.2024.1279680 | 2024 | ||
| Genetics | miMatch: a microbial metabolic background matching tool for mitigating host confounding in metagenomics research. | Liu L, Cao S, Lin W, Gao Z, Yang L, Zhu L, Yang B, Zhang G, Zhu R, Wu D. | Gut Microbes | 10.1080/19490976.2024.2434029 | 2024 | |
| Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study. | Su Q, Jin C, Bo Z, Yang Y, Wang J, Wang J, Zhou J, Chen Y, Zeng H, Chen G, Wang Y. | Front Microbiol | 10.3389/fmicb.2023.1181328 | 2023 | ||
| Crosstalk between gut microbiota and cancer chemotherapy: current status and trends. | Yang S, Hao S, Ye H, Zhang X. | Discov Oncol | 10.1007/s12672-024-01704-8 | 2024 | ||
| Alteration of the gut microbiome and correlated metabolism in a rat model of long-term depression. | Li Y, Li J, Cheng R, Liu H, Zhao Y, Liu Y, Chen Y, Sun Z, Zhai Z, Wu M, Yan Y, Sun Y, Zhang Z. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1116277 | 2023 | ||
| Genetics | Combined analysis of cross-population healthy adult human microbiome reveals consistent differences in gut microbial characteristics between Western and non-Western countries. | Sheng Y, Wang J, Gao Y, Peng Y, Li X, Huang W, Zhou H, Liu R, Zhang W. | Comput Struct Biotechnol J | 10.1016/j.csbj.2023.11.047 | 2024 | |
| Environmental, socioeconomic, and health factors associated with gut microbiome species and strains in isolated Honduras villages. | Shridhar SV, Beghini F, Alexander M, Singh A, Juarez RM, Brito IL, Christakis NA. | Cell Rep | 10.1016/j.celrep.2024.114442 | 2024 | ||
| Tetragenococcus halophilus Alleviates Intestinal Inflammation in Mice by Altering Gut Microbiota and Regulating Dendritic Cell Activation via CD83. | Islam SMS, Ryu HM, Sohn S. | Cells | 10.3390/cells11121903 | 2022 | ||
| Effects of Glucosinolate-Enriched Red Radish (Raphanus sativus) on In Vitro Models of Intestinal Microbiota and Metabolic Syndrome-Related Functionalities. | Roses C, Garcia-Ibanez P, Agudelo A, Viadel B, Tomas-Cobos L, Gallego E, Carvajal M, Milagro FI, Barcelo A. | ACS Omega | 10.1021/acsomega.2c08128 | 2023 | ||
| Phylogeny | Impact of a Model Used to Simulate Chronic Socio-Environmental Stressors Encountered during Spaceflight on Murine Intestinal Microbiota. | Alauzet C, Cunat L, Wack M, Lanfumey L, Legrand-Frossi C, Lozniewski A, Agrinier N, Cailliez-Grimal C, Frippiat JP. | Int J Mol Sci | 10.3390/ijms21217863 | 2020 | |
| Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant Therapy. | White MG, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Lutter-Berkova Z, Chang GJ, Futreal A, Wargo JA, Ajami NJ, Kopetz S, You YN. | Ann Surg | 10.1097/sla.0000000000006015 | 2023 | ||
| Intestinal Permeability Associated with the Loss of Skeletal Muscle Strength in Middle-Aged and Older Adults in Rural Area of Beijing, China. | Li C, Li Y, Wang N, Ge Z, Shi Z, Wang J, Ding B, Bi Y, Wang Y, Hong Z. | Healthcare (Basel) | 10.3390/healthcare10061100 | 2022 | ||
| Metabolomic analysis of gut metabolites in patients with colorectal cancer: Association with disease development and outcome. | Xie Z, Zhu R, Huang X, Yao F, Jin S, Huang Q, Wang D, Li H, Wang Q, Long H, Wu Q. | Oncol Lett | 10.3892/ol.2023.13944 | 2023 | ||
| Genetics | Dynamic changes in gut microbiota during pregnancy among Chinese women and influencing factors: A prospective cohort study. | Li M, Zhang G, Cui L, Zhang L, Zhou Q, Mu C, Chi R, Zhang N, Ma G. | Front Microbiol | 10.3389/fmicb.2023.1114228 | 2023 | |
| Phylogeny | An insight into intestinal mucosal microbiota disruption after stroke. | Stanley D, Moore RJ, Wong CHY. | Sci Rep | 10.1038/s41598-017-18904-8 | 2018 | |
| Metabolism | Role of intestinal flora in the development of nonalcoholic fatty liver disease in children. | Zhang J, Shi M, Zhao C, Liang G, Li C, Ge X, Pei C, Kong Y, Li D, Yang W, Cao B, Fu L, Yan Y, Wu J, Zhou J, Fang Y, Meng X, Li Y, Wang L, Wang L. | Microbiol Spectr | 10.1128/spectrum.01006-23 | 2024 | |
| Proteome | Insights into the proteomic profile of newly harvested corn and metagenomic analysis of the broiler intestinal microbiota. | Yin D, Wang Y, Wang L, Wu Y, Bian X, Aggrey SE, Yuan J. | J Anim Sci Biotechnol | 10.1186/s40104-021-00656-1 | 2022 | |
| Phylogeny | The impact of gut microbiota changes on the intestinal mucus barrier in burned mice: a study using 16S rRNA and metagenomic sequencing. | Zha X, Su S, Wu D, Zhang P, Wei Y, Fan S, Huang Q, Peng X. | Burns Trauma | 10.1093/burnst/tkad056 | 2023 | |
| Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. | Li R, Shokri F, Rincon AL, Rivadeneira F, Medina-Gomez C, Ahmadizar F. | Genes (Basel) | 10.3390/genes14081572 | 2023 | ||
| Genetics | Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma. | Zhang Y, Han S, Xiao X, Zheng L, Chen Y, Zhang Z, Gao X, Zhou S, Yu K, Huang L, Fu J, Hong Y, Jiang J, Qian W, Yang H, Shen J. | Front Immunol | 10.3389/fimmu.2023.1146861 | 2023 | |
| Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment. | Han Q, Li J, Li Z, Aishajiang R, Yu D. | Mater Today Bio | 10.1016/j.mtbio.2025.101601 | 2025 | ||
| Phylogeny | Far infrared radiation induces changes in gut microbiota and activates GPCRs in mice. | Khan I, Pathan S, Li XA, Leong WK, Liao WL, Wong V, Hsiao WLW. | J Adv Res | 10.1016/j.jare.2019.12.003 | 2020 | |
| Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients. | Elbere I, Silamikelis I, Dindune II, Kalnina I, Briviba M, Zaharenko L, Silamikele L, Rovite V, Gudra D, Konrade I, Sokolovska J, Pirags V, Klovins J. | PLoS One | 10.1371/journal.pone.0241338 | 2020 | ||
| Microbiota as a state-of-the-art approach in precision medicine for pancreatic cancer management: A comprehensive systematic review. | Hesami Z, Sabzehali F, Khorsand B, Alipour S, Sadeghi A, Asri N, Pazienza V, Houri H. | iScience | 10.1016/j.isci.2025.112314 | 2025 | ||
| Modulation of Anti-Tumour Immune Responses by Probiotic Bacteria. | Aindelis G, Chlichlia K. | Vaccines (Basel) | 10.3390/vaccines8020329 | 2020 | ||
| Phylogeny | Composition of the Gut Microbiota Associated with the Response to Immunotherapy in Advanced Cancer Patients: A Chinese Real-World Pilot Study. | Cheng X, Wang J, Gong L, Dong Y, Shou J, Pan H, Yu Z, Fang Y. | J Clin Med | 10.3390/jcm11185479 | 2022 | |
| Pathogenicity | Secoisolariciresinol diglucoside attenuates neuroinflammation and cognitive impairment in female Alzheimer's disease mice via modulating gut microbiota metabolism and GPER/CREB/BDNF pathway. | Jia M, Ning F, Wen J, Wang X, Chen J, Hu J, Chen X, Liu Z. | J Neuroinflammation | 10.1186/s12974-024-03195-4 | 2024 | |
| The Bacteroidetes Q-rule and glutaminyl cyclase activity increase the stability of extracytoplasmic proteins. | Szczesniak K, Veillard F, Scavenius C, Chudzik K, Ferenc K, Bochtler M, Potempa J, Mizgalska D. | mBio | 10.1128/mbio.00980-23 | 2023 | ||
| Metabolism | Microbiome and pancreatic cancer: time to think about chemotherapy. | de Castilhos J, Tillmanns K, Blessing J, Larano A, Borisov V, Stein-Thoeringer CK. | Gut Microbes | 10.1080/19490976.2024.2374596 | 2024 | |
| Phylogeny | Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota. | Bars-Cortina D, Ramon E, Rius-Sansalvador B, Guino E, Garcia-Serrano A, Mach N, Khannous-Lleiffe O, Saus E, Gabaldon T, Ibanez-Sanz G, Rodriguez-Alonso L, Mata A, Garcia-Rodriguez A, Obon-Santacana M, Moreno V. | BMC Genomics | 10.1186/s12864-024-10621-7 | 2024 | |
| Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers. | Liu Z, Hong LL, Ling ZQ. | Cancer Med | 10.1002/cam4.6298 | 2023 | ||
| Genetics | Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease. | Kong L, Lloyd-Price J, Vatanen T, Seksik P, Beaugerie L, Simon T, Vlamakis H, Sokol H, Xavier RJ. | Gastroenterology | 10.1053/j.gastro.2020.08.045 | 2020 | |
| Systemic metabolic depletion of gut microbiome undermines responsiveness to melanoma immunotherapy. | Zakharevich NV, Morozov MD, Kanaeva VA, Filippov MS, Zyubko TI, Ivanov AB, Ulyantsev VI, Klimina KM, Olekhnovich EI. | Life Sci Alliance | 10.26508/lsa.202302480 | 2024 | ||
| The Influence of Essential Oils on Gut Microbial Profiles in Pigs. | Ruzauskas M, Bartkiene E, Stankevicius A, Bernatoniene J, Zadeike D, Lele V, Starkute V, Zavistanaviciute P, Grigas J, Zokaityte E, Pautienius A, Juodeikiene G, Jakstas V. | Animals (Basel) | 10.3390/ani10101734 | 2020 | ||
| Genetics | Characteristics of the gut microbiome in esports players compared with those in physical education students and professional athletes. | Kulecka M, Fraczek B, Balabas A, Czarnowski P, Zeber-Lubecka N, Zapala B, Baginska K, Glowienka M, Szot M, Skorko M, Kluska A, Piatkowska M, Mikula M, Ostrowski J. | Front Nutr | 10.3389/fnut.2022.1092846 | 2022 | |
| Phylogeny | Modulation of Gut Microbial Community and Metabolism by Dietary Glycyl-Glutamine Supplementation May Favor Weaning Transition in Piglets. | Yan Y, Xu B, Yin B, Xu X, Niu Y, Tang Y, Wang X, Xie C, Yang T, Zhou S, Yan X, Ma L. | Front Microbiol | 10.3389/fmicb.2019.03125 | 2019 | |
| Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups. | West KA, Yin X, Rutherford EM, Wee B, Choi J, Chrisman BS, Dunlap KL, Hannibal RL, Hartono W, Lin M, Raack E, Sabino K, Wu Y, Wall DP, David MM, Dabbagh K, DeSantis TZ, Iwai S. | Sci Rep | 10.1038/s41598-022-21327-9 | 2022 | ||
| Metabolism | Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers. | Zidi O, Souai N, Raies H, Ben Ayed F, Mezlini A, Mezrioui S, Tranchida F, Sabatier JM, Mosbah A, Cherif A, Shintu L, Kouidhi S. | Molecules | 10.3390/molecules26082266 | 2021 | |
| Healthy adult gut microbiota sustains its own vitamin B12 requirement in an in vitro batch fermentation model. | Kundra P, Geirnaert A, Pugin B, Morales Martinez P, Lacroix C, Greppi A. | Front Nutr | 10.3389/fnut.2022.1070155 | 2022 | ||
| Comprehensive Analysis Reveals Novel Interactions between Circulating MicroRNAs and Gut Microbiota Composition in Human Obesity. | Assmann TS, Cuevas-Sierra A, Riezu-Boj JI, Milagro FI, Martinez JA. | Int J Mol Sci | 10.3390/ijms21249509 | 2020 | ||
| Identification of the Crucial Role of CCL22 in F. nucleatum-Related Colorectal Tumorigenesis that Correlates With Tumor Microenvironment and Immune Checkpoint Therapy. | Wang H, Luo K, Guan Z, Li Z, Xiang J, Ou S, Tao Y, Ran S, Ye J, Ma T, Qiao T, Zhang Z, Jin Y, Song Y, Huang R. | Front Genet | 10.3389/fgene.2022.811900 | 2022 | ||
| Bio-Fermented Malic Acid Facilitates the Production of High-Quality Chicken via Enhancing Muscle Antioxidant Capacity of Broilers. | Qiu K, He W, Zhang H, Wang J, Wang J, Qi G, Guo N, Zhang X, Wu S. | Antioxidants (Basel) | 10.3390/antiox11122309 | 2022 | ||
| Pathogenicity | Alcohol pretreatment of stools effect on culturomics. | Afouda P, Hocquart M, Pham TP, Kuete E, Ngom II, Dione N, Valles C, Bellali S, Lagier JC, Dubourg G, Raoult D. | Sci Rep | 10.1038/s41598-020-62068-x | 2020 | |
| Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy. | Aarnoutse R, Ziemons J, Hillege LE, de Vos-Geelen J, de Boer M, Bisschop SMP, Vriens BEPJ, Vincent J, van de Wouw AJ, Le GN, Venema K, Rensen SS, Penders J, Smidt ML. | NPJ Breast Cancer | 10.1038/s41523-022-00455-5 | 2022 | ||
| Synergistic activity of Enterococcus Faecium-induced ferroptosis via expansion of IFN-gamma+CD8+ T cell population in advanced hepatocellular carcinoma treated with sorafenib. | Yu H, Lin G, Jiang J, Yao J, Pan Z, Xie H, Bo Z, He Q, Yang J, Chen Z, Li J, Wang Y, Yu Z, Assaraf YG, Chen G. | Gut Microbes | 10.1080/19490976.2024.2410474 | 2024 | ||
| Genetics | Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy. | Olekhnovich EI, Ivanov AB, Babkina AA, Sokolov AA, Ulyantsev VI, Fedorov DE, Ilina EN. | mSystems | 10.1128/msystems.01023-22 | 2023 | |
| Gut-resident microorganisms and their genes are associated with cognition and neuroanatomy in children. | Bonham KS, Fahur Bottino G, McCann SH, Beauchemin J, Weisse E, Barry F, Cano Lorente R, RESONANCE Consortium, Huttenhower C, Bruchhage M, D'Sa V, Deoni S, Klepac-Ceraj V. | Sci Adv | 10.1126/sciadv.adi0497 | 2023 | ||
| Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis. | Guo M, Wu G, Tan Y, Li Y, Jin X, Qi W, Guo X, Zhang C, Zhu Z, Zhao L. | mBio | 10.1128/mbio.03519-22 | 2023 | ||
| Pathogenicity | Effects of Lactobacillus plantarum Q180 on Postprandial Lipid Levels and Intestinal Environment: A Double-Blind, Randomized, Placebo-Controlled, Parallel Trial. | Park YE, Kim MS, Shim KW, Kim YI, Chu J, Kim BK, Choi IS, Kim JY. | Nutrients | 10.3390/nu12010255 | 2020 | |
| Genetics | Gut Microbiome Alterations in Patients With Thyroid Nodules. | Li A, Li T, Gao X, Yan H, Chen J, Huang M, Wang L, Yin D, Li H, Ma R, Zeng Q, Ding S. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.643968 | 2021 | |
| Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites. | Garcia Mansilla MJ, Rodriguez Sojo MJ, Lista AR, Ayala Mosqueda CV, Ruiz Malagon AJ, Galvez J, Rodriguez Nogales A, Rodriguez Sanchez MJ. | Nutrients | 10.3390/nu17010155 | 2024 | ||
| The Obesity-Related Gut Bacterial and Viral Dysbiosis Can Impact the Risk of Colon Cancer Development. | Campisciano G, de Manzini N, Delbue S, Cason C, Cosola D, Basile G, Ferrante P, Comar M, Palmisano S. | Microorganisms | 10.3390/microorganisms8030431 | 2020 | ||
| Phylogeny | Effects of Different Ambient Temperatures on Caecal Microbial Composition in Broilers. | Yang Y, Li X, Cao Z, Qiao Y, Lin Q, Liu J, Zhao Z, An Q, Zhang C, Zhang H, Pan H. | Pol J Microbiol | 10.33073/pjm-2021-001 | 2021 | |
| Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions. | Chen J, Siliceo SL, Ni Y, Nielsen HB, Xu A, Panagiotou G. | Microbiome | 10.1186/s40168-023-01604-z | 2023 | ||
| Alterations in co-abundant bacteriome in colorectal cancer and its persistence after surgery: a pilot study. | Png CW, Chua YK, Law JH, Zhang Y, Tan KK. | Sci Rep | 10.1038/s41598-022-14203-z | 2022 | ||
| Deep metagenomic characterization of gut microbial community and function in preeclampsia. | Lv LJ, Li SH, Wen JY, Wang GY, Li H, He TW, Lv QB, Xiao MC, Duan HL, Chen MC, Yi ZT, Yan QL, Yin AH. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.933523 | 2022 | ||
| Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. | Pandey H, Tang DWT, Wong SH, Lal D. | Cancers (Basel) | 10.3390/cancers15030866 | 2023 | ||
| The Effect of Antibiotics Treatment on the Maternal Immune Response and Gut Microbiome in Pregnant and Non-Pregnant Mice. | Faas MM, Liu Y, Wekema L, Weiss GA, van Loo-Bouwman CA, Silva Lagos L. | Nutrients | 10.3390/nu15122723 | 2023 | ||
| Dietary fibers boost gut microbiota-produced B vitamin pool and alter host immune landscape. | Grant ET, Parrish A, Boudaud M, Hunewald O, Hirayama A, Ollert M, Fukuda S, Desai MS. | Microbiome | 10.1186/s40168-024-01898-7 | 2024 | ||
| Metabolism | Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells. | An J, Kim JB, Yang EY, Kim HO, Lee WH, Yang J, Kwon H, Paik NS, Lim W, Kim YK, Moon BI. | Medicine (Baltimore) | 10.1097/md.0000000000025835 | 2021 | |
| Potential links between the microbiota and T cell immunity determine the tumor cell fate. | Mohseni AH, Taghinezhad-S S, Casolaro V, Lv Z, Li D. | Cell Death Dis | 10.1038/s41419-023-05560-2 | 2023 | ||
| A Method for Isolation and Proteomic Analysis of Outer Membrane Vesicles from Fecal Samples by LC-MS/MS. | Wu J, An M, Zhu J, Tan Z, Chen GY, Stidham RW, Lubman DM. | J Proteomics Bioinform | 10.4172/0974-276x.1000494 | 2019 | ||
| Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial. | Borgers JSW, Burgers FH, Terveer EM, van Leerdam ME, Korse CM, Kessels R, Flohil CC, Blank CU, Schumacher TN, van Dijk M, Henderickx JGE, Keller JJ, Verspaget HW, Kuijper EJ, Haanen JBAG. | BMC Cancer | 10.1186/s12885-022-10457-y | 2022 | ||
| Gut microbiota and their influence in brain cancer milieu. | BharathwajChetty B, Kumar A, Deevi P, Abbas M, Alqahtani A, Liang L, Sethi G, Liu L, Kunnumakkara AB. | J Neuroinflammation | 10.1186/s12974-025-03434-2 | 2025 | ||
| Comparison of Yacon (Smallanthus sonchifolius) Tuber with Commercialized Fructo-oligosaccharides (FOS) in Terms of Physiology, Fermentation Products and Intestinal Microbial Communities in Rats. | Utami NW, Sone T, Tanaka M, Nakatsu CH, Saito A, Asano K. | Biosci Microbiota Food Health | 10.12938/bmfh.32.167 | 2013 | ||
| Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer. | Temraz S, Nassar F, Nasr R, Charafeddine M, Mukherji D, Shamseddine A. | Int J Mol Sci | 10.3390/ijms20174155 | 2019 | ||
| Metabolism | Dynamic Alterations of the Gut Microbial Pyrimidine and Purine Metabolism in the Development of Liver Cirrhosis. | Xiong Y, Wu L, Shao L, Wang Y, Huang Z, Huang X, Li C, Wu A, Liu Z, Fan X, Zhou P. | Front Mol Biosci | 10.3389/fmolb.2021.811399 | 2021 | |
| Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth. | Testerman T, Li Z, Galuppo B, Graf J, Santoro N. | Hepatol Commun | 10.1002/hep4.1944 | 2022 | ||
| Pathogenicity | Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbation. | Draper LA, Ryan FJ, Dalmasso M, Casey PG, McCann A, Velayudhan V, Ross RP, Hill C. | BMC Biol | 10.1186/s12915-020-00906-0 | 2020 | |
| Risk factors for type 1 diabetes, including environmental, behavioural and gut microbial factors: a case-control study. | Traversi D, Rabbone I, Scaioli G, Vallini C, Carletto G, Racca I, Ala U, Durazzo M, Collo A, Ferro A, Carrera D, Savastio S, Cadario F, Siliquini R, Cerutti F. | Sci Rep | 10.1038/s41598-020-74678-6 | 2020 | ||
| Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases. | Anwer EKE, Ajagbe M, Sherif M, Musaibah AS, Mahmoud S, ElBanbi A, Abdelnaser A. | Biomedicines | 10.3390/biomedicines13010100 | 2025 | ||
| Gut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer. | Ishaq HM, Mohammad IS, Hussain R, Parveen R, Shirazi JH, Fan Y, Shahzad M, Hayat K, Li H, Ihsan A, Muhammad KS, Usman M, Zhang S, Yuan L, Ullah S, Paiva-Santos AC, Xu J. | J Cancer | 10.7150/jca.66816 | 2022 | ||
| Host metabolome and faecal microbiome shows potential interactions impacted by age and weaning times in calves. | Amin N, Schwarzkopf S, Troscher-Mussotter J, Camarinha-Silva A, Danicke S, Huber K, Frahm J, Seifert J. | Anim Microbiome | 10.1186/s42523-023-00233-z | 2023 | ||
| Proof of Concept of Culturomics Use of Time of Care. | Naud S, Khelaifia S, Mbogning Fonkou MD, Dione N, Lagier JC, Raoult D. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.524769 | 2020 | ||
| Microbiota Induced Changes in the Immune Response in Pregnant Mice. | Faas MM, Liu Y, Borghuis T, van Loo-Bouwman CA, Harmsen H, de Vos P. | Front Immunol | 10.3389/fimmu.2019.02976 | 2019 | ||
| The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice. | Asseri AH, Bakhsh T, Abuzahrah SS, Ali S, Rather IA. | Front Pharmacol | 10.3389/fphar.2023.1208044 | 2023 | ||
| Metabolism | Intestinal inflammation alters mucosal carbohydrate foraging and monosaccharide incorporation into microbial glycans. | Weiss GA, Grabinger T, Glaus Garzon J, Hasler T, Greppi A, Lacroix C, Khanzhin N, Hennet T. | Cell Microbiol | 10.1111/cmi.13269 | 2021 | |
| Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial. | Zhang X, Ren H, Zhao C, Shi Z, Qiu L, Yang F, Zhou X, Han X, Wu K, Zhong H, Li Y, Li J, Ji L. | Diabetologia | 10.1007/s00125-022-05768-5 | 2022 | ||
| Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients. | Marfil-Sanchez A, Seelbinder B, Ni Y, Varga J, Berta J, Hollosi V, Dome B, Megyesfalvi Z, Dulka E, Galffy G, Weiss GJ, Panagiotou G, Lohinai Z. | PLoS One | 10.1371/journal.pone.0259898 | 2021 | ||
| Phage-encoded carbohydrate-interacting proteins in the human gut. | Rothschild-Rodriguez D, Hedges M, Kaplan M, Karav S, Nobrega FL. | Front Microbiol | 10.3389/fmicb.2022.1083208 | 2022 | ||
| Phylogeny | Bacterial rose garden for metagenomic SNP-based phylogeny visualization. | Alexeev D, Bibikova T, Kovarsky B, Melnikov D, Tyakht A, Govorun V. | BioData Min | 10.1186/s13040-015-0045-5 | 2015 | |
| Metabolism | Neutrophil Extracellular Traps Promote the Development and Growth of Human Salivary Stones. | Schapher M, Koch M, Weidner D, Scholz M, Wirtz S, Mahajan A, Herrmann I, Singh J, Knopf J, Leppkes M, Schauer C, Gruneboom A, Alexiou C, Schett G, Iro H, Munoz LE, Herrmann M. | Cells | 10.3390/cells9092139 | 2020 | |
| Genetics | Phenotypic and Genomic Diversification in Complex Carbohydrate-Degrading Human Gut Bacteria. | Pudlo NA, Urs K, Crawford R, Pirani A, Atherly T, Jimenez R, Terrapon N, Henrissat B, Peterson D, Ziemer C, Snitkin E, Martens EC. | mSystems | 10.1128/msystems.00947-21 | 2022 | |
| Genetics | Positive Synergistic Effects of Quercetin and Rice Bran on Human Gut Microbiota Reduces Enterobacteriaceae Family Abundance and Elevates Propionate in a Bioreactor Model. | Ghimire S, Wongkuna S, Sankaranarayanan R, Ryan EP, Bhat GJ, Scaria J. | Front Microbiol | 10.3389/fmicb.2021.751225 | 2021 | |
| Oral and gut dysbiosis leads to functional alterations in Parkinson's disease. | Jo S, Kang W, Hwang YS, Lee SH, Park KW, Kim MS, Lee H, Yoon HJ, Park YK, Chalita M, Lee JH, Sung H, Lee JY, Bae JW, Chung SJ. | NPJ Parkinsons Dis | 10.1038/s41531-022-00351-6 | 2022 | ||
| Metabolism | Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma. | Ianiro G, Rossi E, Thomas AM, Schinzari G, Masucci L, Quaranta G, Settanni CR, Lopetuso LR, Armanini F, Blanco-Miguez A, Asnicar F, Consolandi C, Iacovelli R, Sanguinetti M, Tortora G, Gasbarrini A, Gasbarrini A, Segata N, Cammarota G. | Nat Commun | 10.1038/s41467-020-18127-y | 2020 | |
| Pathogenicity | Gut dysbiosis associates with cytokine production capacity in viral-suppressed people living with HIV. | Zhang Y, Andreu-Sanchez S, Vadaq N, Wang D, Matzaraki V, van der Heijden WA, Gacesa R, Weersma RK, Zhernakova A, Vandekerckhove L, de Mast Q, Joosten LAB, Netea MG, van der Ven AJAM, Fu J. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1202035 | 2023 | |
| Cell-Free Supernatant of Odoribacter splanchnicus Isolated From Human Feces Exhibits Anti-colorectal Cancer Activity. | Oh BS, Choi WJ, Kim JS, Ryu SW, Yu SY, Lee JS, Park SH, Kang SW, Lee J, Jung WY, Kim YM, Jeong JH, Lee JH. | Front Microbiol | 10.3389/fmicb.2021.736343 | 2021 | ||
| mEnrich-seq: methylation-guided enrichment sequencing of bacterial taxa of interest from microbiome. | Cao L, Kong Y, Fan Y, Ni M, Tourancheau A, Ksiezarek M, Mead EA, Koo T, Gitman M, Zhang XS, Fang G. | Nat Methods | 10.1038/s41592-023-02125-1 | 2024 | ||
| Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice. | Hao Y, Zhou P, Zhu YJ, Zou S, Zhao Q, Yu J, Hu Y, Li J. | Front Microbiol | 10.3389/fmicb.2022.853566 | 2022 | ||
| Pathogenicity | N-(1-carbamoyl-2-phenylethyl) butyramide reduces antibiotic-induced intestinal injury, innate immune activation and modulates microbiota composition. | Lama A, Annunziata C, Coretti L, Pirozzi C, Di Guida F, Nitrato Izzo A, Cristiano C, Mollica MP, Chiariotti L, Pelagalli A, Lembo F, Meli R, Mattace Raso G. | Sci Rep | 10.1038/s41598-019-41295-x | 2019 | |
| Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity. | Guo Y, Liu Y, Rui B, Lei Z, Ning X, Liu Y, Li M. | Front Immunol | 10.3389/fimmu.2023.1171680 | 2023 | ||
| Pathogenicity | Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid. | Low L, Suleiman K, Shamdas M, Bassilious K, Poonit N, Rossiter AE, Acharjee A, Loman N, Murray PI, Wallace GR, Rauz S. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.780354 | 2022 | |
| Rumen Microbiome and Metabolome of Tibetan Sheep (Ovis aries) Reflect Animal Age and Nutritional Requirement. | Li H, Yu Q, Li T, Shao L, Su M, Zhou H, Qu J. | Front Vet Sci | 10.3389/fvets.2020.00609 | 2020 | ||
| Metabolism | IMPARO: inferring microbial interactions through parameter optimisation. | Vidanaarachchi R, Shaw M, Tang SL, Halgamuge S. | BMC Mol Cell Biol | 10.1186/s12860-020-00269-y | 2020 | |
| Enzymology | Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial. | Kwak S, Choi J, Hink T, Reske KA, Blount K, Jones C, Bost MH, Sun X, Burnham CD, Dubberke ER, Dantas G, CDC Prevention Epicenter Program. | Microbiome | 10.1186/s40168-020-00907-9 | 2020 | |
| Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis. | Gomez-Perez AM, Ruiz-Limon P, Salas-Salvado J, Vioque J, Corella D, Fito M, Vidal J, Atzeni A, Torres-Collado L, Alvarez-Sala A, Martinez MA, Goday A, Benaiges D, Garcia-Gavilan J, Bernal Lopez MR, Moreno-Indias I, Tinahones FJ. | Gut Microbes | 10.1080/19490976.2023.2223339 | 2023 | ||
| Proteome | Development of an Integrated Pipeline for Profiling Microbial Proteins from Mouse Fecal Samples by LC-MS/MS. | Wu J, Zhu J, Yin H, Liu X, An M, Pudlo NA, Martens EC, Chen GY, Lubman DM. | J Proteome Res | 10.1021/acs.jproteome.6b00450 | 2016 | |
| Metabolism | Concentrated Raw Fibers Enhance the Fiber-Degrading Capacity of a Synthetic Human Gut Microbiome. | Steimle A, Neumann M, Grant ET, Turner JD, Desai MS. | Int J Mol Sci | 10.3390/ijms22136855 | 2021 | |
| Investigation of Immunomodulatory and Gut Microbiota-Altering Properties of Multicomponent Nutraceutical Prepared from Lactic Acid Bacteria, Bovine Colostrum, Apple Production By-Products and Essential Oils. | Grigas J, Ruzauskas M, Pautienius A, Bartkiene E, Lele V, Starkute V, Zavistanaviciute P, Zokaityte E, Bernatoniene J, Ivanauskas L, Jakstas V, Stankevicius A. | Foods | 10.3390/foods10061313 | 2021 | ||
| Pathogenicity | Oral Supplements of Combined Bacillus licheniformis Zhengchangsheng® and Xylooligosaccharides Improve High-Fat Diet-Induced Obesity and Modulate the Gut Microbiota in Rats. | Li Y, Liu M, Liu H, Wei X, Su X, Li M, Yuan J. | Biomed Res Int | 10.1155/2020/9067821 | 2020 | |
| Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy. | Li W, Deng X, Chen T. | Front Oncol | 10.3389/fonc.2021.644454 | 2021 | ||
| Pathogenicity | The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals. | Singh P, Rawat A, Alwakeel M, Sharif E, Al Khodor S. | Sci Rep | 10.1038/s41598-020-77806-4 | 2020 | |
| Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. | Knisely A, Seo YD, Wargo JA, Chelvanambi M. | Cancers (Basel) | 10.3390/cancers15030777 | 2023 | ||
| Biomarkers of response to PD-1 pathway blockade. | Li H, van der Merwe PA, Sivakumar S. | Br J Cancer | 10.1038/s41416-022-01743-4 | 2022 | ||
| Microbiome in Cancer Development and Treatment. | Ciernikova S, Sevcikova A, Mladosievicova B, Mego M. | Microorganisms | 10.3390/microorganisms12010024 | 2023 | ||
| Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. | Ding C, Tang W, Fan X, Wu G. | Onco Targets Ther | 10.2147/ott.s170626 | 2018 | ||
| Metabolism | Metabolic Fate and Distribution of 2´-Fucosyllactose: Direct Influence on Gut Microbial Activity but not on Brain. | Kuntz S, Kunz C, Borsch C, Vazquez E, Buck R, Reutzel M, Eckert GP, Rudloff S. | Mol Nutr Food Res | 10.1002/mnfr.201900035 | 2019 | |
| Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. | Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, Zitvogel L. | Nat Rev Clin Oncol | 10.1038/s41571-023-00785-8 | 2023 | ||
| Discovery of bioactive microbial gene products in inflammatory bowel disease. | Zhang Y, Bhosle A, Bae S, McIver LJ, Pishchany G, Accorsi EK, Thompson KN, Arze C, Wang Y, Subramanian A, Kearney SM, Pawluk A, Plichta DR, Rahnavard A, Shafquat A, Xavier RJ, Vlamakis H, Garrett WS, Krueger A, Huttenhower C, Franzosa EA. | Nature | 10.1038/s41586-022-04648-7 | 2022 | ||
| The Debate between the Human Microbiota and Immune System in Treating Aerodigestive and Digestive Tract Cancers: A Review. | Domingues C, Cabral C, Jarak I, Veiga F, Dourado M, Figueiras A. | Vaccines (Basel) | 10.3390/vaccines11030492 | 2023 | ||
| Genetics | Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men. | Ma W, Nguyen LH, Song M, Wang DD, Franzosa EA, Cao Y, Joshi A, Drew DA, Mehta R, Ivey KL, Strate LL, Giovannucci EL, Izard J, Garrett W, Rimm EB, Huttenhower C, Chan AT. | Genome Med | 10.1186/s13073-021-00921-y | 2021 | |
| Gut microbiota in regulatory T cell generation and function: mechanisms and health implications. | Sharma A, Sharma G, Im SH. | Gut Microbes | 10.1080/19490976.2025.2516702 | 2025 | ||
| The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer. | Parida S, Sharma D. | Biochim Biophys Acta Rev Cancer | 10.1016/j.bbcan.2019.04.001 | 2019 | ||
| An online atlas of human plasma metabolite signatures of gut microbiome composition. | Dekkers KF, Sayols-Baixeras S, Baldanzi G, Nowak C, Hammar U, Nguyen D, Varotsis G, Brunkwall L, Nielsen N, Eklund AC, Bak Holm J, Nielsen HB, Ottosson F, Lin YT, Ahmad S, Lind L, Sundstrom J, Engstrom G, Smith JG, Arnlov J, Orho-Melander M, Fall T. | Nat Commun | 10.1038/s41467-022-33050-0 | 2022 | ||
| The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders. | Lam GA, Albarrak H, McColl CJ, Pizarro A, Sanaka H, Gomez-Nguyen A, Cominelli F, Paes Batista da Silva A. | Inflamm Bowel Dis | 10.1093/ibd/izac241 | 2023 | ||
| Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice. | Parrish A, Boudaud M, Grant ET, Willieme S, Neumann M, Wolter M, Craig SZ, De Sciscio A, Cosma A, Hunewald O, Ollert M, Desai MS. | Nat Microbiol | 10.1038/s41564-023-01464-1 | 2023 | ||
| The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease. | Ruigrok RAAA, Collij V, Sureda P, Klaassen MAY, Bolte LA, Jansen BH, Voskuil MD, Fu J, Wijmenga C, Zhernakova A, Weersma RK, Vich Vila A. | J Crohns Colitis | 10.1093/ecco-jcc/jjab020 | 2021 | ||
| The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts. | Liwinski T, Heinemann M, Schramm C. | Semin Immunopathol | 10.1007/s00281-022-00936-6 | 2022 | ||
| Short-chain fatty acids promote the effect of environmental signals on the gut microbiome and metabolome in mice. | Marrocco F, Delli Carpini M, Garofalo S, Giampaoli O, De Felice E, Di Castro MA, Maggi L, Scavizzi F, Raspa M, Marini F, Tomassini A, Nicolosi R, Cason C, Trettel F, Miccheli A, Iebba V, D'Alessandro G, Limatola C. | Commun Biol | 10.1038/s42003-022-03468-9 | 2022 | ||
| Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels. | Mirhakkak MH, Schauble S, Klassert TE, Brunke S, Brandt P, Loos D, Uribe RV, Senne de Oliveira Lino F, Ni Y, Vylkova S, Slevogt H, Hube B, Weiss GJ, Sommer MOA, Panagiotou G. | ISME J | 10.1038/s41396-020-00848-z | 2021 | ||
| Genetics | An individualized mosaic of maternal microbial strains is transmitted to the infant gut microbial community. | Koo H, McFarland BC, Hakim JA, Crossman DK, Crowley MR, Rodriguez JM, Benveniste EN, Morrow CD. | R Soc Open Sci | 10.1098/rsos.192200 | 2020 | |
| Transcriptome | Mechanism of the Immunomodulatory Effect of the Combination of Live Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus on Immunocompromised Rats. | Lv L, Mu D, Du Y, Yan R, Jiang H. | Front Immunol | 10.3389/fimmu.2021.694344 | 2021 | |
| A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. | Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, Iliev ID. | Cell | 10.1016/j.cell.2022.09.015 | 2022 | ||
| The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases. | Zhang D, Li S, Wang N, Tan HY, Zhang Z, Feng Y. | Front Microbiol | 10.3389/fmicb.2020.00301 | 2020 | ||
| Dietary multi-enzyme complex improves In Vitro nutrient digestibility and hind gut microbial fermentation of pigs. | Recharla N, Kim D, Ramani S, Song M, Park J, Balasubramanian B, Puligundla P, Park S. | PLoS One | 10.1371/journal.pone.0217459 | 2019 | ||
| Pathogenicity | Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment. | Pop M, Paulson JN, Chakraborty S, Astrovskaya I, Lindsay BR, Li S, Bravo HC, Harro C, Parkhill J, Walker AW, Walker RI, Sack DA, Stine OC. | BMC Genomics | 10.1186/s12864-016-2777-0 | 2016 | |
| Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity. | Wilson BC, Vatanen T, Jayasinghe TN, Leong KSW, Derraik JGB, Albert BB, Chiavaroli V, Svirskis DM, Beck KL, Conlon CA, Jiang Y, Schierding W, Holland DJ, Cutfield WS, O'Sullivan JM. | Microbiome | 10.1186/s40168-021-01060-7 | 2021 | ||
| Phylogeny | 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome. | Dong S, Jiao J, Jia S, Li G, Zhang W, Yang K, Wang Z, Liu C, Li D, Wang X. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.634981 | 2021 | |
| Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction. | Sugihara K, Kitamoto S, Saraithong P, Nagao-Kitamoto H, Hoostal M, McCarthy C, Rosevelt A, Muraleedharan CK, Gillilland MG, Imai J, Omi M, Bishu S, Kao JY, Alteri CJ, Barnich N, Schmidt TM, Nusrat A, Inohara N, Golob JL, Kamada N. | Cell Rep | 10.1016/j.celrep.2022.111093 | 2022 | ||
| Intestinal Microbiota in Colorectal Cancer Surgery. | Koliarakis I, Athanasakis E, Sgantzos M, Mariolis-Sapsakos T, Xynos E, Chrysos E, Souglakos J, Tsiaoussis J. | Cancers (Basel) | 10.3390/cancers12103011 | 2020 | ||
| The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship. | Sampsell K, Hao D, Reimer RA. | Int J Mol Sci | 10.3390/ijms21239239 | 2020 | ||
| Phylogeny | Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. | Shiao SL, Kershaw KM, Limon JJ, You S, Yoon J, Ko EY, Guarnerio J, Potdar AA, McGovern DPB, Bose S, Dar TB, Noe P, Lee J, Kubota Y, Maymi VI, Davis MJ, Henson RM, Choi RY, Yang W, Tang J, Gargus M, Prince AD, Zumsteg ZS, Underhill DM. | Cancer Cell | 10.1016/j.ccell.2021.07.002 | 2021 | |
| Pathogenicity | Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment. | Pizzo F, Maroccia Z, Hammarberg Ferri I, Fiorentini C. | Int J Mol Sci | 10.3390/ijms23116138 | 2022 | |
| Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. | Dong X, Pan P, Zheng DW, Bao P, Zeng X, Zhang XZ. | Sci Adv | 10.1126/sciadv.aba1590 | 2020 | ||
| Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response. | Zhang H, Fu L, Leiliang X, Qu C, Wu W, Wen R, Huang N, He Q, Cheng Q, Liu G, Cheng Y. | Cancer Commun (Lond) | 10.1002/cac2.12597 | 2024 | ||
| Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment. | Sawant SS, Patil SM, Gupta V, Kunda NK. | Int J Mol Sci | 10.3390/ijms21207575 | 2020 | ||
| Responses of Intestinal Mucosal Barrier Functions of Rats to Simulated Weightlessness. | Jin M, Zhang H, Zhao K, Xu C, Shao D, Huang Q, Shi J, Yang H. | Front Physiol | 10.3389/fphys.2018.00729 | 2018 | ||
| Pathogenicity | Whole Blueberry and Isolated Polyphenol-Rich Fractions Modulate Specific Gut Microbes in an In Vitro Colon Model and in a Pilot Study in Human Consumers. | Ntemiri A, Ghosh TS, Gheller ME, Tran TTT, Blum JE, Pellanda P, Vlckova K, Neto MC, Howell A, Thalacker-Mercer A, O'Toole PW. | Nutrients | 10.3390/nu12092800 | 2020 | |
| The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review. | Agnes A, Puccioni C, D'Ugo D, Gasbarrini A, Gasbarrini A, Biondi A, Persiani R. | BMC Surg | 10.1186/s12893-021-01087-5 | 2021 | ||
| Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. | Fong W, Li Q, Yu J. | Oncogene | 10.1038/s41388-020-1341-1 | 2020 | ||
| Metabolism | Using Tn-seq To Identify Pigmentation-Related Genes of Porphyromonas gingivalis: Characterization of the Role of a Putative Glycosyltransferase. | Klein BA, Cornacchione LP, Collins M, Malamy MH, Duncan MJ, Hu LT. | J Bacteriol | 10.1128/jb.00832-16 | 2017 | |
| Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease. | Chen Z, Xie Y, Zhou F, Zhang B, Wu J, Yang L, Xu S, Stedtfeld R, Chen Q, Liu J, Zhang X, Xu H, Ren J. | Front Microbiol | 10.3389/fmicb.2020.00383 | 2020 | ||
| Gastrointestinal cancers: the role of microbiota in carcinogenesis and the role of probiotics and microbiota in anti-cancer therapy efficacy. | Kazmierczak-Siedlecka K, Ruszkowski J, Skonieczna-Zydecka K, Jedrzejczak J, Folwarski M, Makarewicz W. | Cent Eur J Immunol | 10.5114/ceji.2020.103353 | 2020 | ||
| Genetics | Multi-omics gut microbiome signatures in obese women: role of diet and uncontrolled eating behavior. | Barone M, Garelli S, Rampelli S, Agostini A, Matysik S, D'Amico F, Krautbauer S, Mazza R, Salituro N, Fanelli F, Iozzo P, Sanz Y, Candela M, Brigidi P, Pagotto U, Turroni S. | BMC Med | 10.1186/s12916-022-02689-3 | 2022 | |
| Toward an improved definition of a healthy microbiome for healthy aging. | Ghosh TS, Shanahan F, O'Toole PW. | Nat Aging | 10.1038/s43587-022-00306-9 | 2022 | ||
| Genetics | Structure of the Mucosal and Stool Microbiome in Lynch Syndrome. | Yan Y, Drew DA, Markowitz A, Lloyd-Price J, Abu-Ali G, Nguyen LH, Tran C, Chung DC, Gilpin KK, Meixell D, Parziale M, Schuck M, Patel Z, Richter JM, Kelsey PB, Garrett WS, Chan AT, Stadler ZK, Huttenhower C. | Cell Host Microbe | 10.1016/j.chom.2020.03.005 | 2020 | |
| Pathogenicity | Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth. | Li Y, Elmen L, Segota I, Xian Y, Tinoco R, Feng Y, Fujita Y, Segura Munoz RR, Schmaltz R, Bradley LM, Ramer-Tait A, Zarecki R, Long T, Peterson SN, Ronai ZA. | Cell Rep | 10.1016/j.celrep.2020.01.035 | 2020 | |
| Gut dysbiosis contributes to amyloid pathology, associated with C/EBPbeta/AEP signaling activation in Alzheimer's disease mouse model. | Chen C, Ahn EH, Kang SS, Liu X, Alam A, Ye K. | Sci Adv | 10.1126/sciadv.aba0466 | 2020 | ||
| Interactions between gut microbiota and skeletal muscle. | Gizard F, Fernandez A, De Vadder F. | Nutr Metab Insights | 10.1177/1178638820980490 | 2020 | ||
| Multifaceted modes of action of the anticancer probiotic Enterococcus hirae. | Goubet AG, Wheeler R, Fluckiger A, Qu B, Lemaitre F, Iribarren K, Mondragon L, Tidjani Alou M, Pizzato E, Durand S, Derosa L, Aprahamian F, Bossut N, Moya-Nilges M, Derrien D, Chen G, Leduc M, Joseph A, Pons N, Le Chatelier E, Segata N, Yonekura S, Iebba V, Kepp O, Raoult D, Andre F, Kroemer G, Boneca IG, Zitvogel L, Daillere R. | Cell Death Differ | 10.1038/s41418-021-00753-8 | 2021 | ||
| A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis. | Fouhy F, Ronan NJ, O'Sullivan O, McCarthy Y, Walsh AM, Murphy DM, Daly M, Flanagan ET, Fleming C, McCarthy M, Shortt C, Eustace JA, Shanahan F, Rea MC, Ross RP, Stanton C, Plant BJ. | Sci Rep | 10.1038/s41598-017-06880-y | 2017 | ||
| Effect of antimicrobial growth promoter administration on the intestinal microbiota of beef cattle. | Reti KL, Thomas MC, Yanke LJ, Selinger LB, Inglis GD. | Gut Pathog | 10.1186/1757-4749-5-8 | 2013 | ||
| Enzymology | Succinivibrionaceae is dominant family in fecal microbiota of Behçet's Syndrome patients with uveitis. | Tecer D, Gogus F, Kalkanci A, Erdogan M, Hasanreisoglu M, Ergin C, Karakan T, Kozan R, Coban S, Diker KS. | PLoS One | 10.1371/journal.pone.0241691 | 2020 | |
| Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark. | Pinna NK, Anjana RM, Saxena S, Dutta A, Gnanaprakash V, Rameshkumar G, Aswath S, Raghavan S, Rani CSS, Radha V, Balasubramanyam M, Pant A, Nielsen T, Jorgensen T, Faerch K, Kashani A, Silva MCA, Vestergaard H, Hansen TH, Hansen T, Arumugam M, Nair GB, Das B, Pedersen O, Mohan V, Mande SS. | Genome Med | 10.1186/s13073-021-00851-9 | 2021 | ||
| Phylogeny | Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. | Lagkouvardos I, Lesker TR, Hitch TCA, Galvez EJC, Smit N, Neuhaus K, Wang J, Baines JF, Abt B, Stecher B, Overmann J, Strowig T, Clavel T. | Microbiome | 10.1186/s40168-019-0637-2 | 2019 | |
| Automated analysis of genomic sequences facilitates high-throughput and comprehensive description of bacteria. | Hitch TCA, Riedel T, Oren A, Overmann J, Lawley TD, Clavel T. | ISME Commun | 10.1038/s43705-021-00017-z | 2021 | ||
| Genetics | Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. | Gomez A, Luckey D, Yeoman CJ, Marietta EV, Berg Miller ME, Murray JA, White BA, Taneja V. | PLoS One | 10.1371/journal.pone.0036095 | 2012 | |
| Metabolism | An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection. | Antharam VC, McEwen DC, Garrett TJ, Dossey AT, Li EC, Kozlov AN, Mesbah Z, Wang GP. | PLoS One | 10.1371/journal.pone.0148824 | 2016 | |
| Big Data Approaches for Modeling Response and Resistance to Cancer Drugs. | Jiang P, Sellers WR, Liu XS. | Annu Rev Biomed Data Sci | 10.1146/annurev-biodatasci-080917-013350 | 2018 | ||
| Metabolism | Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. | Miko E, Kovacs T, Sebo E, Toth J, Csonka T, Ujlaki G, Sipos A, Szabo J, Mehes G, Bai P. | Cells | 10.3390/cells8040293 | 2019 | |
| Pathogenicity | Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. | Gasparrini AJ, Wang B, Sun X, Kennedy EA, Hernandez-Leyva A, Ndao IM, Tarr PI, Warner BB, Dantas G. | Nat Microbiol | 10.1038/s41564-019-0550-2 | 2019 | |
| Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. | De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R. | PLoS One | 10.1371/journal.pone.0076993 | 2013 | ||
| Pathogenicity | Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease. | Fornelos N, Franzosa EA, Bishai J, Annand JW, Oka A, Lloyd-Price J, Arthur TD, Garner A, Avila-Pacheco J, Haiser HJ, Tolonen AC, Porter JA, Clish CB, Sartor RB, Huttenhower C, Vlamakis H, Xavier RJ. | Nat Microbiol | 10.1038/s41564-019-0655-7 | 2020 | |
| Enzymology | State of the Art in the Culture of the Human Microbiota: New Interests and Strategies. | Tidjani Alou M, Naud S, Khelaifia S, Bonnet M, Lagier JC, Raoult D. | Clin Microbiol Rev | 10.1128/cmr.00129-19 | 2020 | |
| Metabolism | NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. | Chen L, Wilson JE, Koenigsknecht MJ, Chou WC, Montgomery SA, Truax AD, Brickey WJ, Packey CD, Maharshak N, Matsushima GK, Plevy SE, Young VB, Sartor RB, Ting JP. | Nat Immunol | 10.1038/ni.3690 | 2017 | |
| The Glutaminase-Dependent Acid Resistance System: Qualitative and Quantitative Assays and Analysis of Its Distribution in Enteric Bacteria. | Pennacchietti E, D'Alonzo C, Freddi L, Occhialini A, De Biase D. | Front Microbiol | 10.3389/fmicb.2018.02869 | 2018 | ||
| Phylogeny | Molecular diversity of rumen bacterial communities from tannin-rich and fiber-rich forage fed domestic Sika deer (Cervus nippon) in China. | Li ZP, Liu HL, Li GY, Bao K, Wang KY, Xu C, Yang YF, Yang FH, Wright AD. | BMC Microbiol | 10.1186/1471-2180-13-151 | 2013 | |
| Microbial markers in colorectal cancer detection and/or prognosis. | Villeger R, Lopes A, Veziant J, Gagniere J, Barnich N, Billard E, Boucher D, Bonnet M. | World J Gastroenterol | 10.3748/wjg.v24.i22.2327 | 2018 | ||
| Genetics | Comparative Genomic Analysis of the Human Gut Microbiome Reveals a Broad Distribution of Metabolic Pathways for the Degradation of Host-Synthetized Mucin Glycans and Utilization of Mucin-Derived Monosaccharides. | Ravcheev DA, Thiele I. | Front Genet | 10.3389/fgene.2017.00111 | 2017 | |
| Metabolism | Gut microbiota functions: metabolism of nutrients and other food components. | Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. | Eur J Nutr | 10.1007/s00394-017-1445-8 | 2018 | |
| Pathogenicity | Adjusting for age improves identification of gut microbiome alterations in multiple diseases. | Ghosh TS, Das M, Jeffery IB, O'Toole PW. | Elife | 10.7554/elife.50240 | 2020 | |
| Phylogeny | Genome-Based Taxonomic Classification of Bacteroidetes. | Hahnke RL, Meier-Kolthoff JP, Garcia-Lopez M, Mukherjee S, Huntemann M, Ivanova NN, Woyke T, Kyrpides NC, Klenk HP, Goker M. | Front Microbiol | 10.3389/fmicb.2016.02003 | 2016 | |
| Phylogeny | Coprobacter fastidiosus gen. nov., sp. nov., a novel member of the family Porphyromonadaceae isolated from infant faeces. | Shkoporov AN, Khokhlova EV, Chaplin AV, Kafarskaia LI, Nikolin AA, Polyakov VY, Shcherbakova VA, Chernaia ZA, Efimov BA. | Int J Syst Evol Microbiol | 10.1099/ijs.0.052126-0 | 2013 | |
| Genetics | Noncontiguous finished genome sequence and description of Gabonia massiliensis gen. nov., sp. nov. | Mourembou G, Rathored J, Ndjoyi-Mbiguino A, Lekana-Douki JB, Fenollar F, Robert C, Fournier PE, Raoult D, Lagier JC. | New Microbes New Infect | 10.1016/j.nmni.2015.11.002 | 2016 | |
| Phylogeny | Dialister succinatiphilus sp. nov. and Barnesiella intestinihominis sp. nov., isolated from human faeces. | Morotomi M, Nagai F, Sakon H, Tanaka R | Int J Syst Evol Microbiol | 10.1099/ijs.0.2008/000810-0 | 2008 |
| #15518 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 21032 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 ) |
| #31196 | Barberan A, Caceres Velazquez H, Jones S, Fierer N.: Hiding in Plain Sight: Mining Bacterial Species Records for Phenotypic Trait Information. mSphere 2: 2017 ( DOI 10.1128/mSphere.00237-17 , PubMed 28776041 ) - originally annotated from #27523 (see below) |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68380 | Automatically annotated from API rID32A . |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive12519.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data